Articles

2026

Clin Res Cardiol. 2026 Jun 22. doi: 10.1007/s00392-026-02957-9. Online ahead of print. PMID: 42329403

Revascularization with drug-coated balloons alone in complex coronary artery disease: a systematic review.

Kunz M, Götzinger F, Tjeerdsma M, Korah A, Cortese B, Rissanen TT, Scheller B, Chapman AR, Mahfoud F, Leibundgut G, Boeddinghaus J.

Catheter Cardiovasc Interv. 2026 Jun 2. doi: 10.1002/ccd.70669. Online ahead of print. PMID: 42227724

Impact of Strut Thickness for Patients Treated With Percutaneous Revascularization for Coronary Bifurcations: Insights From the BIFURCAT-ULTRA Registry.

Michelone M, D’Ascenzo F, Cho YK, Kang J, De Luca L, Cimino AR, Choi KH, Di Pietro G, Bertello E, Mattesini A, Wanha W, Lee SY, Gili S, Kim HK, Capoccia S, Greco A, Iannaccone M, Lee HJ, Cortese B, Song YB, Capodanno D, Gwon HC, Bruno F, Tuttolomondo D, Koo BK, De Ferrari GM, Nam CW, De Filippo O.

J Am Heart Assoc. 2026 Jun 2;15(11):e051188. doi: 10.1161/JAHA.126.051188. Epub 2026 May 29. PMID: 42216286

Paclitaxel Noninferior to Paclitaxel: Registry-Scale Evidence for an Urea-Excipient Drug-Coated Balloon in a Real World Population: A Commentary on the SCAAR Nationwide Comparative Registry Analysis.

Cortese B, Murad E.

Catheter Cardiovasc Interv. 2026 May 26. doi: 10.1002/ccd.70672. Online ahead of print. PMID: 42187185

Intravascular Imaging-Guided Percutaneous Coronary Intervention Versus Coronary Artery Bypass Grafting for Unprotected Left Main Stenosis.

Wańha W, Kuźma Ł, Święczkowski M, Dąbrowski E, Iwańczyk S, Lesiak M, Kowalewski M, Dobrzycki S, Kralisz P, Kowalówka A, Makhoul M, Morshed K, Wita K, Gocoł R, Hudziak D, Wojakowski W, De la Torre Hernández JM, Cortese B.

JACC Cardiovasc Interv. 2026 May 25;19(10):1322-1325. doi: 10.1016/j.jcin.2026.02.028. Epub 2026 Apr 17. PMID: 41995639 

Antiplatelet Management After PCI With Drug-Coated Balloon: Focusing on the Finger and Not the Stars.

Fezzi S, Yahyavi A, Cortese B.

J Am Heart Assoc. 2026 May 19;15(10):e046625. doi: 10.1161/JAHA.125.046625. Epub 2026 May 14. PMID: 42132197 

Primary Results of the SALAMANDER Registry: A Multicenter Observational Cohort Study.

Wańha W, Kuźma Ł, Kowalewski M, Iwańczyk S, Grygier J, Jeske J, Frazzetto M, Litwinowicz R, Burysz M, Gaszewska-Żurek E, Sanfilippo C, Bochenek T, Lelek M, Wita K, Huczek Z, Kapłon-Cieślicka A, Mazurek T, Scisło P, Sacha J, Struniawski K, Tomasiewicz B, Mezque F, Kuliczkowski W, Bartuś K, Dobrzycki S, Święczkowski M, Kurasz A, Kralisz P, Miśkowiec D, Kasprzak JD, Chamera M, Mielczarek M, Drewla P, Gałąska R, Ugo F, Franzino M, Cortese B, Gurgoglione FL, Vignali L, Benatti G, Barocelli F, Waciński P, Niezgoda P, Sukiennik A, Kubica J, Iannacone M, Kowalska K, Lewicki Ł, Grasso C, Capodanno D, D’Ascenzo F, de Filippo O, Bruno F, Gocoł R, Kalarus Z, Suwalski P, Grygier M, Smolka G, Lip GYH, Wojakowski W.

Eur Heart J. 2026 May 5;47(17):2035-2043. doi: 10.1093/eurheartj/ehag070. PMID: 41711522 

Great debate: drug-coated balloons are preferable to drug-eluting stents for coronary in-stent restenosis.

Cortese B, Mehilli J, Belmonte M, Wanha W, Barbato E.

Eur J Intern Med. 2026 May;147:106794. doi: 10.1016/j.ejim.2026.106794. Epub 2026 Mar 2. PMID: 41775576 

Microvascular angina: it’s time to move beyond fixed paradigms.

De Servi S, Landi A, Cortese B.

Am J Cardiol. 2026 Mar 25:S0002-9149(26)00197-9. doi: 10.1016/j.amjcard.2026.03.044. Online ahead of print.PMID: 41895362

Drug-Coated Balloon Versus Drug-Eluting Stent for Coronary Revascularization in Patients with Chronic Kidney Disease: A Real-World Propensity-Matched Study.

Gurgoglione FL, Frazzetto M, Gitto M, Leone PP, Iwańczyk S, Wańha W, Bossi I, Latini RA, Chiarito M, Godino C, Sardella G, Stefanini G, Colombo A, Cortese

AsiaIntervention. 2026 Mar 19;12(1):28-40. doi: 10.4244/AIJ-D-25-00057. eCollection 2026 Mar.PMID: 41835989

Angiographic and functional assessment after paclitaxel or sirolimus drug-coated balloons for de novo coronary artery disease in small vessels: PICCOLETO VI study.

Fezzi S, Gitto M, Trevisanello A, Sharif F, Venturi G, Bezubka J, Iwanczyk S, Wanha W, Hawranek M, Mielczarek M, Wańczura P, Verdoia M, Pieri P, Mugnolo A, Khialani B, Litovchik I, Monayer A, Rissanen TT, Ribichini F, Colombo A, Cortese B.

Cardiovasc Diabetol. 2026 Mar 4. doi: 10.1186/s12933-026-03110-6. Online ahead of print.PMID: 41776495

Nanocarrier SIroliMus-coated balloon-based percutaneous coronary intervention (PCI) versus drug-eluting stent (DES)-onLy PCI in patients with diabetes mellitus.

Gitto M, Filiberti G, Leone PP, Chiarito M, Gurgoglione FL, Tartaglia F, Frazzetto M, Calamita G, Rossi ML, Bernardini V, Reimers B, Regazzoli D, Mangieri A, Gasparini G, Briguori C, Latib A, Stefanini GG, Godino C, Sardella G, Cortese B, Colombo A.

Eur J Intern Med. 2026 Mar 2:106794. doi: 10.1016/j.ejim.2026.106794. Online ahead of print.PMID: 41775576 No abstract available.

Microvascular angina: it’s time to move beyond fixed paradigms.

De Servi S, Landi A, Cortese B.

Eur Heart J. 2026 Feb 19:ehag070. doi: 10.1093/eurheartj/ehag070. Online ahead of print.PMID: 41711522

Great debate: drug-coated balloons are preferable to drug-eluting stents for coronary in-stent restenosis.

Cortese B, Mehilli J, Belmonte M, Wanha W, Barbato E.

Am Heart J. 2026 Jun;296:107361. doi: 10.1016/j.ahj.2026.107361. Epub 2026 Feb 4.PMID: 41651102 Review.

Antiplatelet treatment after drug-coated balloon treatment: Review of the current evidence and future perspectives.

Cortese B, Mohammed AA, Malakouti S, Sivalingam J, Chaddad R, El-Mokdad R, Gurgoglione FL, Valgimigli M.

J Am Coll Cardiol. 2026 Jan 27;87(3):330-332. doi: 10.1016/j.jacc.2025.12.003.PMID: 41603510 No abstract available.

REC-CAGEFREE I 3-Year Outcomes: A Step Backward for Drug-Coated Balloons in De Novo Interventions?

Cortese B, Frazzetto M.

2025

PLoS One. 2025 Dec 29;20(12):e0337991. doi: 10.1371/journal.pone.0337991. eCollection 2025.PMID: 41460848

Long-term outcomes following drug-coated balloons versus thin-strut drug-eluting stents for treatment of in-stent restenosis in Chronic Kidney Disease (CKD Dragon-Registry).

Januszek R, Chamera M, Iwańczyk S, D’Ascenzo F, Kuźma Ł, Tomasiewicz B, Niezgoda P, Wolny R, Kowalewski M, Wybraniec M, Reczuch K, Dobrzycki S, De Filippo O, Pawlik A, Kasprzycki K, Skowron K, Bartuś S, Lesiak M, Gąsior M, Kubica J, Pawłowski T, Gil RJ, Waciński P, Bruno F, Cortese B, Wojakowski W, Wańha W.

J Pers Med. 2025 Dec 3;15(12):594. doi: 10.3390/jpm15120594.

Role of Polymer-Free Drug-Eluting Stents in Insulin-Dependent Diabetic Patients Undergoing Percutaneous Coronary Intervention: An Observational Study.

Gurgoglione FL, Donelli D, Frazzetto M, Vignali L, Benatti G, Tadonio I, Denegri A, Covani M, De Gregorio M, Dallaglio G, Niccoli G, Cortese B, Solinas E.

REC Interv Cardiol. 2025 Sep 29;7(4):272-275. doi: 10.24875/RECICE.M25000532. eCollection 2025.PMID: 41333117

Sirolimus-coated balloon in young versus old patients with coronary artery disease: a sub-analysis of the EASTBOURNE study.

Luca Gurgoglione F, Ielasi A, Bossi I, Latini R, Cortese B.

Eur J Intern Med. 2026 Jan;143:106603. doi: 10.1016/j.ejim.2025.106603. Epub 2025 Nov 30.PMID: 41320627

Management of patients without obstructive coronary arteries and suspected microvascular angina: Is it time for a paradigm shift?

De Servi S, Landi A, Cortese B.

J Clin Med. 2025 Nov 20;14(22):8234. doi: 10.3390/jcm14228234.PMID: 41303270 

Balancing Safety and Efficacy: Factor XIa INHIBITORS vs. DOACs in Patients with Atrial Fibrillation: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.

Khater J, Frazzetto M, Mahmud SH, Yahyavi A, Malakouti S, Khialani B, Cortese B.

J Clin Med. 2025 Nov 11;14(22):7976. doi: 10.3390/jcm14227976.PMID: 41303012 

No-Reflow During Coronary Interventions: A Narrative Review.

Malakouti S, Hashim A, Frazzetto M, Cortese B.

J Clin Med. 2025 Oct 25;14(21):7576. doi: 10.3390/jcm14217576.PMID: 41226975

Blended Coronary Revascularization with Drug-Coated Balloon and Drug-Eluting Stent: A Narrative Review on Rationale, Clinical Evidence, and Future Perspectives.

Gurgoglione FL, Murad E, Frazzetto M, Cortese B.

JACC Cardiovasc Interv. 2025 Nov 10;18(21):2638-2640. doi: 10.1016/j.jcin.2025.09.021.PMID: 41224393 No abstract available.

3-Year Outcomes With a Sirolimus-Coated Balloon for Femoropopliteal Disease: A New “Selution” for Peripheral Interventions?

Cortese B, Frazzetto M.

Cardiol J. 2026;33:e00226020. doi: 10.5603/cj.103075. Epub 2025 Nov 5.PMID: 41191008

Temporal trends in the use of drug-coated balloons in Poland – an analysis based on the national registry.

Januszek R, Iwańczyk S, Wojakowski W, Huczek Z, Janas A, Włodarczak A, Wolny R, Opolski MP, Dziarmaga M, Bujak K, Hawranek M, Malinowski KP, Kaźmierski M, Waciński P, Gąsior P, Siudak Z, Kłak M, Niezgoda P, Cortese B, Wańha W.

Cardiovasc Diabetol. 2025 Oct 27;24(1):408. doi: 10.1186/s12933-025-02922-2.PMID: 41146181

Drug-coated balloons and diabetes: a review.

Frazzetto M, Malakouti S, Khialani B, Gurgoglione FL, Cortese B.

Lancet. 2025 Oct 25;406(10514):1950. doi: 10.1016/S0140-6736(25)01859-8.PMID: 41139095 

Drug-coated balloon angioplasty and stenting for coronary artery lesions.

Gurgoglione FL, Cortese B.

EuroIntervention. 2025 Oct 20;21(20):e1177-e1197. doi: 10.4244/EIJ-D-25-00201.PMID: 41071571

Drug-coated balloons for coronary bifurcation lesions.

Fezzi S, Scheller B, Rissanen TT, Malivojevic R, Tavella D, Lunardi M, Cortese B, Banning A, Pesarini G, Ribichini F, Scarsini R.

J Am Coll Cardiol. 2025 Oct 14;86(15):1170-1202. doi: 10.1016/j.jacc.2025.07.049.PMID: 41062231

Indications for Use of Drug-Coated Balloons in Coronary Intervention: Academic Research Consortium Position Statement.

Fezzi S, Serruys PW, Cortese B, Scheller B, Alfonso F, Jeger R, Colombo A, Joner M, Shin ES, Kleber F, Latib A, Rissanen TT, Eccleshall S, Ribichini F, Tao L, Koo BK, Chieffo A, Ge J, Granada JF, Stoll HP, Spaulding C, Cavalcante R, Abizaid A, Muramatsu T, Boudoulas KD, Waksman R, Mehran R, Cutlip D, Krucoff M, Stone GW, Garg S, Onuma Y.

Am J Cardiol. 2026 Jan 1;258:268-275. doi: 10.1016/j.amjcard.2025.09.039. Epub 2025 Sep 27.PMID: 41022246.

GLP-1 Receptor Agonists and Cardiovascular Outcomes in Adults With Diabetes and Peripheral Artery Disease: An Updated Systematic Review and Meta-Analysis.

Shuja SH, Shuja MH, Shaukat A, Hannat R, Ahmed I, Adam S, Abdelkhalek A, Changez MIK, Ullah I, Ahmed R, Cortese B.

J Soc Cardiovasc Angiogr Interv. 2025 Jun 30;4(8):103810. doi: 10.1016/j.jscai.2025.103810. eCollection 2025 Aug.PMID: 41019909 

Charting the Course and Uncharted Territories: SCAI 2025 Guidelines for Chronic Venous Disease.

Irfan Ullah, Khansa Ahmad, Hasim Ahmed, Bernardo Cortese

Lancet. 2025 Sep 20;406(10509):1220. doi: 10.1016/S0140-6736(25)01373-X.PMID: 40975609 

Orbital atherectomy for stent implantation: the ECLIPSE trial.

Khialani B, Frazzetto M, Touma G, Cortese B.

Nanoscale Adv. 2025 Aug 22;7(19):5978-5992. doi: 10.1039/d5na00438a. eCollection 2025 Sep 24.PMID: 40959729 

Exploring magnetoelectric nanoparticles for advanced nano-electroporation and drug delivery in interventional cardiology.

Tommasini A, Suarato G, Fiocchi S, Chiaramello E, Marrella A, Lenzuni M, Parazzini M, Cortese B, Ravazzani P.

Int J Cardiol Heart Vasc. 2025 Sep 1;60:101789. doi: 10.1016/j.ijcha.2025.101789. eCollection 2025 Oct.PMID: 40948729 

Drug-coated balloon angioplasty for chronic total coronary occlusions. Blended strategies: the best of two worlds.

Alfonso F, Cortese B, Brilakis ES.

J Geriatr Cardiol. 2025 Aug 28;22(8):701-708. doi: 10.26599/1671-5411.2025.08.002.PMID: 40919345 

Clinical characteristics, therapeutic strategies, and outcomes in elderly patients on oral anticoagulant therapy undergoing percutaneous coronary interventions: post-hoc analysis of the PERSEO Registry.

Minardi S, De Rosa S, Salvi N, Andò G, Talanas G, D’angelo C, Moretti C, Mazza TM, Cortese B, Musumeci G, Rubboli A, Sciahbasi A.

Catheter Cardiovasc Interv. 2025 Nov;106(5):2880-2889. doi: 10.1002/ccd.70094. Epub 2025 Sep 2.PMID: 40891272

Intravascular Ultrasound Findings Associated With Hydrodynamic Contrast Recanalization (HDR) of Coronary Chronic Total Occlusions.

Arain SA, Nascimbene A, Yarrabothula A, Hudson J, Brilakis ES, Colombo A, Azzalini L, Iqbal MB, Cortese B, Tadano Y, Fujita T, Carlino M, Kar B.

Am J Cardiol. 2025 Aug 13;255:99-105. doi: 10.1016/j.amjcard.2025.08.012. Online ahead of print.PMID: 40816672

Sirolimus-Coated Balloon Versus Drug-Eluting Stent in Elderly Patients With Coronary Artery Disease: A Matched-based Comparison.

Gurgoglione FL, Iwańczyk S, Wańha W, Donelli D, Gattuso D, Niccoli G, Cortese B.

Clin Cardiol. 2025 Aug;48(8):e70191. doi: 10.1002/clc.70191.PMID: 40787966

Mortality Trends Associated With Acute Myocardial Infarction and Psychoactive Substance Use in Older Adults: A US Nationwide Analysis (1999-2020).

Shuja MH, Hannat R, Shahid A, Meer KK, Mubbashir A, Edhi M, Ullah I, Alareed A, Paray NB, Ahmed R, Cortese B, Hall ME.

 Am J Cardiol. 2025 Aug 9;255:89-98. doi: 10.1016/j.amjcard.2025.08.003. Online ahead of print.PMID: 40784468 

Preventive Percutaneous Intervention of Vulnerable Coronary Plaques.

Khialani B, Alfonso F, Malakouti S, Rodrigues ACLF, Reddy K, Garcia HM, Park SJ, Colombo A, la Torre Hernandez JM, Al-Lamee R, Iwańczyk S, Stone G, Cortese B.

AsiaIntervention. 2025 Jul 30;11(2):e129-e138. doi: 10.4244/AIJ-D-24-00044. eCollection 2025 Jul.PMID: 40741162

 Performance of drug-coated balloons in East Asian and Caucasian patients: a post hoc analysis of the EASTBOURNE Registry.

El Khoury A, Malakouti S, Ielasi A, Sivalingam J, Greco A, Khialani BV, Gattuso D, Cortese B.

Int J Cardiol. 2025 Jun 24:133542. doi: 10.1016/j.ijcard.2025.133542. Epub ahead of print. PMID: 40571129.

Duration of dual antiplatelet therapy in patients undergoing percutaneous coronary intervention for bifurcation lesions: Insights from the ULTRA-BIFURCAT registry.

Nebiolo M, Kang J, Sandrone S, Kim HK, Mattesini A, Lee SY, Piccolo R, Lim YH, Perl L, Youn YJ, Cortese B, Park K, Tuttolomondo D, Choo EH, Iannaccone M, Choi KH, Greco A, Cho YK, Leone A, Stefanini G, Bruno F, D’Ascenzo F, Lee HJ, Prof GP, Prof YBS, Campo G, Prof CN, Prof GMF, Prof BK, De Filippo O.

Catheter Cardiovasc Interv. 2025 Jun 19. doi: 10.1002/ccd.31694. Epub ahead of print. PMID: 40537958.

What Is the Role for TAVI in Failing Surgical Aortic Valves? A Review on Valve-in-Valve Interventions.

Reddy K, Malakouti S, Dallan LAP, Attizzani GF, O’Neill WW, Cortese B.

Int J Cardiol Cardiovasc Risk Prev. 2025 May 11;26:200428. doi: 10.1016/j.ijcrp.2025.200428. PMID: 40529294; PMCID: PMC12173663.

Exploring the rising death rates among older US citizens with heart failure and sepsis: Need for health-care policy reform.

Ahad A, Fatima E, Jamil A, Rehman OU, Ullah I, Ahmed R, Cortese B, Hall ME, Mamas MA.

Catheter Cardiovasc Interv. 2025 Jun 4. doi: 10.1002/ccd.31657. Epub ahead of print. PMID: 40468540.

A. Peri-Procedural Management of Oral Anticoagulant Therapy in Patients Undergoing Percutaneous Coronary Intervention: Insights from the PERSEO Multicenter Registry.

Rigattieri S, Cristiano E, De Rosa S, Calabrò P, Talarico GP, Cortese B, Caruso M, Redivo M, Musumeci G, Sciahbasi

J Clin Med. 2025 May 20;14(10):3563. doi: 10.3390/jcm14103563. PMID: 40429558; PMCID: PMC12112029

Peri-Procedural Continuation Versus Interruption of Anticoagulation for Transcatheter Aortic Valve Implantation: A Systematic Review and Meta-Analysis.

Khater J, Frazzetto M, Gurgoglione FL, Hasan J, Donelli D, Attizzani G, Cortese B.

J Cardiovasc Dev Dis. 2025 May 20;12(5):194. doi: 10.3390/jcdd12050194. PMID: 40422965; PMCID: PMC12112549.

Drug-Coated Balloons: Recent Evidence and Upcoming Novelties.

Shahrori ZMF, Frazzetto M, Mahmud SH, Alghwyeen W, Cortese B.

J Cardiovasc Dev Dis. 2025 May 5;12(5):176. doi: 10.3390/jcdd12050176. PMID: 40422946; PMCID: PMC12112498

Leaving Nothing Behind: Expanding the Clinical Frontiers of Drug-Coated Balloon Angioplasty in Coronary Artery Disease.

Marchetta M, Sasso S, Paragliola V, Maffi V, Chiricolo G, Massaro G, Russo G, Benedetto D, Muscoli S, Colonna G, Mandurino-Mirizzi A, Cortese B, Sangiorgi GM, Andò G.

Catheter Cardiovasc Interv. 2025 May 20. doi: 10.1002/ccd.31609. Epub ahead of print. PMID: 40394951

Prognostic Significance of Bailout Stenting for Residual Stenosis or Dissection Following Drug-Coated Balloon Angioplasty: A Sub-Analysis of the EASTBOURNE Study.

Gurgoglione FL, Cortese B.

Cardiovasc Revasc Med. 2025 May 10:S1553-8389(25)00240-4. doi: 10.1016/j.carrev.2025.05.012. Epub ahead of print. PMID: 40393869.

Drug-coated balloons for small vessel disease: Navigating between randomized clinical trials evidence and real-world data.

Frazzetto M, Penna N, Cortese B.

Catheter Cardiovasc Interv. 2025 May 19. doi: 10.1002/ccd.31587. Epub ahead of print. PMID: 40384053.

Comparison of Sirolimus-Versus Paclitaxel-Coated Balloons in Coronary Artery Disease: One-Year Results of Two Real-World Prospective Registries.

Vlieger S, Cheng JM, Gurgoglione FL, Heang TM, Ijsselmuiden AJJ, Ielasi A, Boersma E, Yan LC, Sciahbasi A, Singh R, Karavolias G, Gattuso D, Oemrawsingh RM, Cortese B.

Kardiol Pol. 2025;83(5):556-569. doi: 10.33963/v.phj.105954. Epub 2025 May 14. PMID: 40365890.

How to treat coronary in-stent restenosis? Recent advances and their practical implications: State-of-the-Art Review.

Wańha W, Iwańczyk S, Tajstra M, Cortese B.

Cardiovasc Revasc Med. 2025 Jun;75:137-143. doi: 10.1016/j.carrev.2025.04.002. Epub 2025 Apr 10. PMID: 40274485.

Efficacy of drug-coated balloon angioplasty for coronary chronic total occlusion: A systematic review and meta-analysis.

Gurgoglione FL, Malakouti S, Khialani B, Hasan J, Khater J, Occhipinti G, Donelli D, Cortese B.

EuroIntervention. 2025 Apr 24:EIJ-E-25-00021. doi: 10.4244/EIJ-E-25-00021. Epub ahead of print. PMID: 40272160.

Definitions and standardized endpoints for the use of drug-coated balloon in coronary artery disease: consensus document of the Drug Coated Balloon Academic Research Consortium.

Fezzi S, Scheller B, Cortese B, Alfonso F, Jeger R, Colombo A, Joner M, Shin ES, Kleber FX, Latib A, Rissanen TT, Eccleshall S, Ribichini F, Tao L, Koo BK, Chieffo A, Ge J, Granada JF, Stoll HP, Spaulding C, Cavalcante R, Abizaid A, Muramatsu T, Boudoulas KD, Waksman R, Mehran R, Cutlip DE, Krucoff MW, Stone GW, Garg S, Onuma Y, Serruys PW.

Eur Heart J. 2025 Apr 24:ehaf029. doi: 10.1093/eurheartj/ehaf029. Epub ahead of print. PMID: 40270117.

Definitions and standardized endpoints for the use of drug-coated balloon in coronary artery disease: consensus document of the Drug Coated Balloon Academic Research Consortium.

Fezzi S, Scheller B, Cortese B, Alfonso F, Jeger R, Colombo A, Joner M, Shin ES, Kleber FX, Latib A, Rissanen TT, Eccleshall S, Ribichini F, Tao L, Koo BK, Chieffo A, Ge J, Granada JF, Stoll HP, Spaulding C, Cavalcante R, Abizaid A, Muramatsu T, Boudoulas KD, Waksman R, Mehran R, Cutlip DE, Krucoff MW, Stone GW, Garg S, Onuma Y, Serruys PW.

Hellenic J Cardiol. 2025 Apr 1:S1109-9666(25)00095-8. doi: 10.1016/j.hjc.2025.03.009. Epub ahead of print. PMID: 40180240.

Efficacy of drug-coated balloons versus drug-eluting stents in bifurcated lesions: a systematic review and meta-analysis.

Teperikidis L, Zormpas G, Karakasis P, Patoulias D, Boulmpou A, Kouzoukas DE, Cortese B, Biondi-Zoccai G, Papadopoulos C.

J Am Coll Cardiol. 2025 Apr 8;85(13):1464. doi: 10.1016/j.jacc.2024.12.034. PMID: 40175019.

The Drug-Coated Balloon-Bifurcation Trial (DCB-BIF): A Flash in the Pan?

Lazar L, Khialani B, Cortese B.

Circ Cardiovasc Interv. 2025 Jun;18(6):e014814. doi: 10.1161/CIRCINTERVENTIONS.124.014814. Epub 2025 Apr 2. PMID: 40171656.

Two-Year Clinical Outcomes in Female and Male Patients After Sirolimus-Coated Balloon Angioplasty for Coronary Artery Disease.

Leone PP, Testa L, Greco A, Yan LC, Milazzo D, Benincasa S, Gattuso D, Cortese B; EASTBOURNE Investigators.

EuroIntervention. 2025 Mar 17;21(6):e318-e328. doi: 10.4244/EIJ-D-24-00471. PMID: 40091870; PMCID: PMC11895841.

Final kissing balloon dilatation in patients with coronary bifurcation lesions treated with an upfront provisional stenting strategy.

De Filippo O, Kang J, Bruno F, Song YB, Campagnuolo S, Choi KH, Pinxterhuis TH, Kim HK, Mattesini A, Cho YK, Piccolo R, Lee HJ, Wańha W, Cortese B, Han SH, Perl L, Hur SH, Tuttolomondo D, Iannaccone M, Chun WJ, Greco A, Leone A, Giachet AT, Gwon HC, Stefanini G, Kim HS, Escaned J, Carmeci A, Campo G, Patti G, Capodanno D, von Birgelen C, Koo BK, de Ferrari GM, Nam CW, D’Ascenzo F.

IEEE Rev Biomed Eng. 2025 May 5;PP. doi: 10.1109/RBME.2025.3530244. Epub ahead of print. PMID: 40030885.

Computational Analysis of Intravascular OCT Images for Future Clinical Support: A Comprehensive Review.

Lee J, Gharaibeh Y, Dong P, Dallan LAP, Pereira GTR, Kim JN, Hoori A, Gu L, Bezerra HG, Cortese B, Wilson DL

Eur Heart J. 2025 May 2;46(17):1586-1599. doi: 10.1093/eurheartj/ehaf002. Erratum in: Eur Heart J. 2025 Jun 11:ehaf413. doi: 10.1093/eurheartj/ehaf413. PMID: 39981922.

Individual patient data meta-analysis of paclitaxel-coated balloons vs. drug-eluting stents for small-vessel coronary artery disease: the ANDROMEDA study.

Fezzi S, Giacoppo D, Fahrni G, Latib A, Alfonso F, Colombo A, Mahfoud F, Scheller B, Jeger R, Cortese B.

J Am Heart Assoc. 2025 Feb 4;14(3):e037657. doi: 10.1161/JAHA.124.037657. Epub 2025 Feb 3. PMID: 39895551; PMCID: PMC12074771.

Differential Prognosis of True Bifurcation Lesions According to Left Main Versus Non-Left Main Location and Treatment Strategy.

Choi KH, Nam CW, Bruno F, Cho YK, De Luca L, Kang J, Mattesini A, Song YB, Truffa A, Kim HS, Wańha W, Chun WJ, Gili S, Helft G, Han SH, Cortese B, Lee CH, Escaned J, Yoon HJ, Chieffo A, Hahn JY, Gallone G, Choi SH, De Ferrari G, Koo BK, Quadri G, Hur SH, D’Ascenzo F, Gwon HC, de Filippo O.

Kardiol Pol. 2025;83(2):180-187. doi: 10.33963/v.phj.104188. Epub 2025 Jan 17. PMID: 39821623.

Acute and short-term outcome of Intravascular Coronary Lithotripsy and Excimer Laser Coronary Atherectomy for Severe Stent Underexpansion: The Multicenter IVL-ELCA DRAGON Registry.

Wańha W, Wolny R, Kleczyński P, Mattesini A, Iwańczyk S, Dziarmaga M, Kulczycki J, Kuźma Ł, Gąsior P, Wańczura P, Tomaniak M, Koltowski Ł, Januszek R, Lewicki Ł, Sacha J, Jaguszewski M, Sobieszek G, Kwiatkowski P, Gąsior M, Ochała A, D’Ascenzo F, Nardi G, Bartuś S, Gil RJ, Opolski MP, Pawłowski T, Tomasiewicz B, Kubler P, Reczuch K, Kowalewski M, Dobrzycki S, Kralisz P, Witkowski A, Lesiak M, Włodarczak A, Cortese B, Legutko J, Wojakowski W, Waciński P.

2024

JACC Cardiovasc Interv. 2025 Feb 10;18(3):377-379. doi: 10.1016/j.jcin.2024.11.003. Epub 2025 Jan 8. PMID: 39797838.

All-in-One Integrated Device for Carotid Stenting: The Last Mile to Attain Surgical Revascularization?

Cortese B, Frazzetto M, Shishehbor MH.

Catheter Cardiovasc Interv. 2025 Feb;105(3):643-649. doi: 10.1002/ccd.31376. Epub 2024 Dec 24. PMID: 39718036.

Physiological Performance of Drug-Coated Balloons in Small Coronary Arteries PICCOLETO II

Fezzi S, Trevisanello A, Buccheri D, Borgi M, Orrego PS, Zoccai GB, Cortese B.

Am J Cardiol. 2025 Mar 15;239:68-74. doi: 10.1016/j.amjcard.2024.12.015. Epub 2024 Dec 16. PMID: 39694084.

Predictors and Long-Term Prognostic Significance of Bailout Stenting During Percutaneous Coronary Interventions With Sirolimus-Coated Balloon: A Subanalysis of the Eastbourne Study.

Gurgoglione FL, Gattuso D, Greco A, Benatti G, Niccoli G, Cortese B.

Coron Artery Dis. 2025 Mar 1;36(2):173-176. doi: 10.1097/MCA.0000000000001474. Epub 2024 Dec 18. PMID: 39692432.

Drug-coated balloon coronary angioplasty: where are we going?

Alfonso F, Elgendy IY, Cortese B.

Clin Cardiol. 2024 Dec;47(12):e70058. doi: 10.1002/clc.70058. PMID: 39679968; PMCID: PMC11648035.

Temporal Trends in Mortality Related to Stroke and Atrial Fibrillation in the United States: A 21-Year Retrospective Analysis of CDC-WONDER Database.

Ahmad O, Farooqi HA, Ahmed I, Jamil A, Nabi R, Ullah I, Khan AW, Ahmed R, Alam M, Cortese B, Mamas MA.

Korean Circ J. 2025 Jan;55(1):5-16. doi: 10.4070/kcj.2024.0172. Epub 2024 Oct 11. PMID: 39601395; PMCID: PMC11735155.

Sex Differences in Procedural Characteristics and Clinical Outcomes Among Patients Undergoing Bifurcation PCI.

Ahn HJ, Bruno F, Kang J, Hwang D, Yang HM, Han JK, De Luca L, de Filippo O, Mattesini A, Park KW, Truffa A, Wanha W, Song YB, Gili S, Chun WJ, Helft G, Hur SH, Cortese B, Han SH, Escaned J, Chieffo A, Choi KH, Gallone G, Doh JH, De Ferrari G, Hong SJ, Quadri G, Nam CW, Gwon HC, Kim HS, D’Ascenzo F, Koo BK.

Eur Heart J Qual Care Clin Outcomes. 2024 Nov 20:qcae091. doi: 10.1093/ehjqcco/qcae091. Epub ahead of print. PMID:39567839

Impact of intravascular ultrasound for coronary bifurcations treated with last generations stents: insights from the BIFURCAT-ULTRA registry. –

Bruno F, Choi KH, De Filippo O, Kim HK, Doronzo M, Cho YK, Pinxterhuis TH, Kang J, Mattesini A, Song YB, Piccolo R, Koo BK, Wańha W, Lee J, Cortese B, Gwon HC, Perl L, Kim HS, Tuttolomondo D, Iannaccone M, Chun WJ, Capodanno D, Leone A, Giachet AT, Hur SH, Stefanini G, Han SH, Escaned J, Carmeci A, Campo G, Patti G, von Birgelen C, de Ferrari GM, Nam CW, D’Ascenzo F.

.

Cardiovasc Revasc Med. 2024 Nov 7:S1553-8389(24)00715-2. doi:10.1016/j.carrev.2024.11.003. Epub ahead of print. PMID: 39547832.

Five-year clinical outcomes of STEMI patients treated with a pre-specified bioresorbable vascular scaffold implantation technique: Final results of the BVS STEMI STRATEGY-IT.

Moscarella E, Campo G, Leoncini M, Geraci S, Nicolini E, Cortese B, Loi B, Guiducci V, Saccà S, Varricchio A, Vicinelli P, De Candia G, Personeni D, Calabrò P, Brugaletta S, Latib A, Tespili M, Ielasi A.

Catheter Cardiovasc Interv. 2024 Oct 28. doi: 10.1002/ccd.31257. Epub ahead of print.

Drug-coated balloons in high-risk patients and diabetes mellitus: A meta-analysis of 10 studies.

Verdoia M, Nardin M, Rognoni A, Cortese B.

Int J Cardiol. 2024 Oct 22;419:132677. doi:10.1016/j.ijcard.2024.132677. Epub ahead of print. PMID: 39447703.

Reply to letter regarding “Sirolimus-coated balloon versus drug-eluting stent for complex coronary lesions: A propensity matched comparison”

Iwańczyk S, Wańha W, Cortese B

Catheter Cardiovasc Interv. 2024 17. doi: 10.1002/ccd.31266. Epub ahead of print. PMID: 39420687.

Is the enthusiasm for Drug-Coated balloon technology justified?

Basavarajaiah S, Bhatia G, Cortese B, Khialani B.

Catheter Cardiovasc Interv. 2024 Nov;104(6):1168-1177. doi: 10.1002/ccd.31225. Epub 2024 Oct 9. PMID: 39381995.

Long-term outcomes of DCB and DES for the treatment of in-stent restenosis in relation to the vessel size.

Iwańczyk S, Wolny R, Januszek R, Gil RJ, Cortese B, Kubler P, Wojakowski W, Grygier M, Lesiak M, Wańha W.

Eur Heart J. 2024 Nov 8;45(42):4542-4543. doi: 10.1093/eurheartj/ehae621. PMID: 39319641.

Is intravascular ultrasound needed to optimize drug-coated balloon angioplasty results?

Alfonso Manterola F, Cortese B.

-JACC Cardiovasc Interv. 2024 Oct 14;17(19):2309-2311. doi: 10.1016/j.jcin.2024.07.011. Epub 2024. Sep 18. PMID: 39297857.

Is Delayed Stent Fracture Possible?: A Combined Enhanced Stent Visualization and IVUS Diagnosis.

Venturi G, Mugnolo A, Cortese B.

Trends Cardiovasc Med. 2024 Sep 5:S1050-1738(24)00079-3. doi: 10.1016/j.tcm.2024.08.006. Epub ahead of print. PMID: 39243831.

C. Coronary drug-coated balloons: A comprehensive review of clinical applications and controversies.

Khawaja M, Britt M, Rizwan A, Abraham J, Nguyen T, Munaf U, Khan MA, Arshad H, Munye M, Newman N, Ielasi A, Eccleshall S, Vassiliou VS, Merinopoulos I, Cortese B, Krittanawong

Cardiovasc Revasc Med. 2024 Jul 30:S1553-8389(24)00610-9.

Safety and efficacy of single antiplatelet therapy in a large cohort of patients treated with sirolimus-coated balloon: Post hoc analysis from the prospective EASTBOURNE registry.

Mangier A, Testa L, Heang TM, Bossi I, Lee CY, Perez IS, Milazzo D, Nuruddin AA, Seresini G, Singh R, Cacucci M, Sciahbasi A, Torres A, Sengottvelu G, Colombo A, Cortese B; EASTBOURNE investigators.

Cardiol J. 2024;31(4):507-511.

Are we at dawn of the drug-coated balloons era? Current evidence, future directions, and tasks of the newly established working group of the Association of Cardiovascular Interventions.

Iwańczyk S, Bujak K, Wolny R, Janas A, Dziarmaga M, Opolski MP, Januszek R, Włodarczak A, Desperak P, Niezgoda P, Kryjak M, Tomaniak M, Huczek Z, Hawranek M, Cortese B, Wańha W.

EuroIntervention. 2024 Aug 5;20(15):e954.

Letter: Biological differences of three paclitaxel- and sirolimus-coated balloons on coronary lesions in a rabbit model.

Finn A, Virmani R, Cortese B.

Int J Cardiol. 2024 Aug 15:132436. 

Sirolimus-coated balloon versus drug-eluting stent for complex coronary lesions. A propensity matched comparison.

Iwańczyk S, Lazar FL, Onea HL, Pesenti N, Wańha W, Woźniak P, Gościniak W, Prof ML, Cortese B.

Front Cardiovasc Med. 2024 Jul 25;11:1419018.

Gender differences in outcomes after left atrial appendage closure with Watchman FLX device: insights from the Italian-FLX registry.

Bonanni M, Frazzetto M, Nardone A, Meucci F, Musto C, Quaranta G, Saccà S, Bedogni F, Maffeo D, Ugo F, Guarracini F, Bocuzzi G, Durante A, Granatelli A, Tumminello G, Eusebio G, Grasso C, De Marco F, Cortese B, Mariani M, Berti S.

J Clin Med. 2024 Jul 30;13(15):4464.

Drug-Eluting Balloons and Drug-Eluting Stents in Diabetic Patients Undergoing Percutaneous Coronary Intervention Due to Restenosis-DM-Dragon Registry.

Niezgoda P, Kasprzak M, Kubica J, Kuźma Ł, Januszek R, Iwańczyk S, Tomasiewicz B, Bil J, Kowalewski M, Jaguszewski M, Wybraniec M, Reczuch K, Dobrzycki S, Bartuś S, Lesiak M, Gąsior M, Wolny R, Witkowski A, Gil R, Cortese B, D’Ascenzo F, Wojakowski W, Wańha W.

Cardiovasc Revasc Med. 2024 Jul 28:S1553-8389(24)00608-0.

Angiographic and clinical impact of balloon inflation time in percutaneous coronary interventions with sirolimus-coated balloon: A subanalysis of the EASTBOURNE study.

Gurgoglione FL, Gattuso D, Greco A, Donelli D, Niccoli G, Cortese B.

Future Cardiol. 2024 Aug 6:1-15.

Magic Touch sirolimus-coated balloon: animal and clinical evidence of a coronary sirolimus drug-coated balloon.

Cortese B, Malakouti S, Khater J, Munjal A.

Catheter Cardiovasc Interv. 2024 Jul 30.

Navigating challenges in drug-coated balloon technology: The saga between paclitaxel and sirolimus continues.

Cortese B, Tensol GRP, Dallan LAP, Salerno PRVO, Finn A.

JACC Basic Transl Sci. 2024 Jun 24;9(6):790-791. doi: 10.1016/j.jacbts.2024.04.001. eCollection 2024 Jun.

New Drug-Coated Balloons on the Horizon: The Quest for a Good Balance Between Safety and Efficacy.

Cortese B.

Circ Cardiovasc Interv. 2024 Jul 25:e014064. 

Long-Term Outcomes Following Sirolimus-Coated Balloon or Drug-Eluting Stents for Treatment of In-Stent Restenosis.

Wańha W, Iwańczyk S, Januszek R, Wolny R, Tomasiewicz B, Kuliczkowski W, Reczuch K, Pawlus P, Pawłowski TZ, Kuźma Ł, Kubler P, Niezgoda P, Kubica J, Gil RJ, Pawłowski TF, Gąsior M, Jaguszewski M, Wybraniec M, Witkowski A, Kowalewski M, D’Ascenzo F, Greco A, Bartuś S, Lesiak M, Grygier M, Wojakowski W, Cortese B.

J Cardiovasc Pharmacol. 2024 Jul 19. doi: 10.1097/FJC.0000000000001607. Epub ahead of print. PMID: 39028879.

Management of patients treated with oral anticoagulant therapy undergoing percutaneous coronary intervention with stent implantation: the PERSEO Registry.

Sciahbasi A, De Rosa S, Gargiulo G, Giacoppo D, Calabrò P, Talarico GP, Zilio F, Talanas G, Tebaldi M, Andò G, Rigattieri S, Misuraca L, Cortese B, Musuraca G, Lucci V, Guiducci V, Renda G, Zezza L, Versaci F, Giannico MB, Caruso M, Fischetti D, Colletta M, Santarelli A, Larosa C, Iannone A, Esposito G, Tarantini G, Musumeci G, Rubboli A.

EuroIntervention. 2024 Jul 1;20(13):e831-e833. doi: 10.4244/EIJ-D-23-00966. PMID: 38949239; PMCID: PMC11200662.

Two-year outcomes of sirolimus-coated balloon angioplasty for coronary artery disease: the EASTBOURNE Registry.

Leone PP, Heang TM, Yan LC, Perez IS, Caiazzo G, Geraci S, Jiyen K, Tomai F, Buccheri D, Seresini G, Singh R, Karavolias G, Cacucci M, Ocaranza R, Torres A, Caruso M, Azzalini L, Pesenti N, Colombo A, Cortese B.

Long-term outcomes following paclitaxel-coated balloons versus thin-strut drug eluting stents for treatment of in-stent restenosis in Chronic Coronary Syndrome (CCS Dragon-Registry).

Kardiol Pol. 2024 Jun 18. doi: 10.33963/v.phj.101064. Epub ahead of print. PMID: 38887780.

Wańha W, D’Ascenzo F, Kuźma Ł, Januszek R, Iwańczyk S, Tomasiewicz B, Brzozowski P, Niezgoda P, Kowalewski M, Jaguszewski M, Wybraniec M, Tomaniak M, Pindlowski P, Kochman J, Kubler P, Dobrzycki S, Bartuś S, Lesiak M, Gąsior M, Witkowski A, Kubica J, Gil RJ, Cortese B, Wojakowski W, Wolny R.

JACC Cardiovasc Interv. 2024 May 25:S1936-8798(24)00710-6. doi: 10.1016/j.jcin.2024.04.040. 

mTOR Inhibition by Drug-Coated Balloon: A Thor’s Hammer Against Atherosclerosis?

Cortese B, Shishehbor MH.

Cardiovasc Revasc Med. 2024 Apr 6:S1553-8389(24)00144-1. doi: 10.1016/j.carrev.2024.04.001. 

Editorial: Is the axiom of balloon angioplasty, “the more you gain the more you lose”, still true in the era of DCB with paclitaxel?

Serruys PW, Tobe A, Ninomiya K, Garg S, Finn AV, Scheller B, Cortese B, Colombo A, Reimers B, Basavarajaiah S, Sharif F, Fezzi S, Gao C, Tao L, Onuma Y.

Curr Cardiol Rep. 2024 May;26(5):359-372. doi: 10.1007/s11886-024-02037-2. Epub 2024 Apr 15.

Drug-Coated Balloon in Acute Coronary Syndromes: Ready for the Prime Time?

Fezzi S, Malakouti S, Sivalingam J, Khater J, Ribichini F, Cortese B.

Minerva Cardiol Angiol. 2024 Mar 29. doi: 10.23736/S2724-5683.23.06443-8.

The role of drug-coated balloons for coronary bifurcation management: results from the prospective EASTBOURNE-BIF study.

Lazar FL, Prvulović Đ, Onea HL, Cortese B.

AsiaIntervention. 2024 Feb 29;10(1):15-25. doi: 10.4244/AIJ-D-23-00010.

A 2024 scientific update on the clinical performance of drug-coated balloons.

Lazar FL, Onea HL, Olinic DM, Cortese B.

Catheter Cardiovasc Interv. 2024 Mar;103(4):532-538. doi: 10.1002/ccd.30996.

Long term clinical outcome of sirolimus drug coated balloons in large coronary vessels.

Sciahbasi A, Salvi N, Heang TM, Perez IS, Geraci S, Vaccaro G, Benincasa S, Nuruddin AA, Ocaranza R, Giannini F, Greco A, Cortese B.

Int J Cardiol. 2024 Feb 14:131861. doi: 10.1016/j.ijcard.2024.131861. Epub ahead of print. PMID: 38365014.

Long-term impact of intravascular ultrasound-guided for percutaneous coronary intervention on unprotected left main. The IMPACTUS-LM, an observational, multicentric study.

Bruno F, de Filippo O, Sardone A, Capranzano P, Conrotto F, Sheiban I, Giacobbe F, Laudani C, Burzotta F, Saia F, Escaned J, Roubin SR, Mancone M, Templin C, Candreva A, Trabattoni D, Wanha W, Stefanini G, Chieffo A, Cortese B, Casella G, Wojakowski W, Colombo F, De Ferrari GM, Boccuzzi G, D’Ascenzo F, Iannaccone M.

Cardiovasc Diabetol. 2024 Feb 3;23(1):52. doi: 10.1186/s12933-024-02139-9. PMID: 38310281; PMCID: PMC10838457.

EASTBOURNE investigators. Sirolimus-coated balloon in all-comer population of coronary artery disease patients: the EASTBOURNE DIABETES prospective registry.

Caiazzo G, Oliva A, Testa L, Heang TM, Lee CY, Milazzo D, Stefanini G, Pesenti N, Mangieri A, Colombo A, Cortese B;

J Cardiovasc Med (Hagerstown). 2024 Feb 1. doi: 10.2459/JCM.0000000000001598. Epub ahead of print. PMID: 38305141.

Performance of sodium-glucose cotransporter 2 inhibitors in cardiovascular disease.

Khater J, Malakouti S, Khoury AE, Cortese B.

2023

Am J Cardiol. 2023 Dec 16:S0002-9149(23)01390-5. doi: 10.1016/j.amjcard.2023.12.011. Epub ahead of print. Erratum for: Am J Cardiol. 2023 Nov 1;206:320-329. PMID: 38114059.

Corrigendum to ‘Forecasting the Risk of Heart Failure Hospitalization After Acute Coronary Syndromes: the CORALYS HF Score’

D’Ascenzo F, Fabris E, Gregorio C, Mittone G, De Filippo O, Wańha W, Leonardi S, Roubin SR, Chinaglia A, Truffa A, Huczek Z, Gaibazzi N, Ielasi A, Cortese B, Borin A, Pagliaro B, Núñez-Gil IJ, Ugo F, Marengo G, Barbieri L, Marchini F, Desperak P, Melendo-Viu M, Montalto C, Bianco M, Bruno F, Mancone M, Ferrandez-Escarabajal M, Morici N, Scaglione M, Tuttolomondo D, Gąsior M, Mazurek M, Gallone G, Campo G, Wojakowski W, Assi EA, Stefanini G, Sinagra G, Ferrari GM.

Minerva Cardiol Angiol. 2023 Dec 21. doi: 10.23736/S2724-5683.23.06425-6. Epub ahead of print. PMID: 38127439.

Long-term benefits of drug-coated balloons for coronary artery revascularization.

Cortese B, Malakouti S, Mazhar W, Leontin Lazar F, Munjal A, Ketchanji Mougang Y.

Int J Cardiol. 2024 Feb 15;397:131622. doi: 10.1016/j.ijcard.2023.131622. Epub 2023 Dec 6. PMID: 38061607.

Gender differences in the development of heart failure after acute coronary syndrome: Insight from the CORALYS registry.

Elia E, Bruno F, Crimi G, Wańha W, Leonardi S, Mauro M, Raposeiras Roubin S, Fabris E, Giannino G, Mancone M, Severino P, Truffa A, De Filippo O, Huczek Z, Mazurek M, Gaibazzi N, Ielasi A, Cortese B, Borin A, Núñez-Gil IJ, Marengo G, Melis D, Ugo F, Bianco M, Barbieri L, Marchini F, Desperak P, Morici N, Scaglione M, Gąsior M, Gallone G, Lopiano C, Stefanini G, Campo G, Wojakowski W, Abu-Assi E, Sinagra G, de Ferrari GM, Porto I, D’Ascenzo F.

Catheter Cardiovasc Interv. 2023 Dec;102(7):1238-1257. doi: 10.1002/ccd.30851. Epub 2023 Nov 10. PMID: 37948409.

How to perform a successful drug-coated balloon angioplasty? Tips and tricks.

Basavarajaiah S, Kalkat H, Bhatia G, Cortese B.

Catheter Cardiovasc Interv. 2023 Nov 8. doi: 10.1002/ccd.30906. Online ahead of print.

The fate of coronary dissections left after sirolimus-coated balloon angioplasty: A prespecified subanalysis of the EASTBOURNE study.

El Khoury A, Lazar L, Cortese B.

JACC Cardiovasc Interv. 2023 Oct 17:S1936-8798(23)01321-3.

A Prospective Randomized Trial Comparing Sirolimus-Coated Balloon With Paclitaxel-Coated Balloon in De Novo Small Vessels.

Ninomiya K, Serruys PW, Colombo A, Reimers B, Basavarajaiah S, Sharif F, Testa L, Di Mario C, Nerla R, Ding D, Huang J, Kotoku N, Kageyama S, Kageyama M, Sevestre E, Fezzi S, Dijkstra J, O’Leary N, Morel MA, Garg S, Cortese B, Onuma Y.

Catheter Cardiovasc Interv. 2023 Oct 23. 

The evolution and revolution of drug coated balloons in coronary angioplasty: An up-to-date review of literature data.

Cortese B, Kalkat H, Bathia G, Basavarajaiah S.

Eur Heart J Acute Cardiovasc Care. 2023 Oct 9:zuad122.

Coronary Calcification In Patients Presenting With Acute Coronary Syndromes: Insights From The Matrix Trial.

Sanz Sánchez J, Garcia-Garcia HM, Branca M, Frigoli E, Leonardi S, Gagnor A, Calabrò P, Garducci S, Rubartelli P, Briguori C, Andò G, Repetto A, Limbruno U, Garbo R, Sganzerla P, Russo F, Lupi A, Cortese B, Ausiello A, Ierna S, Esposito G, Santarelli A, Sardella G, Varbella F, Tresoldi S, de Cesare N, Rigattieri S, Zingarelli A, Tosi P, van ‘t Hof A, Boccuzzi G, Omerovic E, Sabaté M, Heg D, Vranckx P, Valgimigli M.

J Clin Med. 2023 Sep 8;12(18):5844.

Functional (Re)Development of SYNTAX Score II 2020: Predictive Performance and Risk Assessment.

Scala A, Erriquez A, Verardi FM, Marrone A, Scollo E, Trichilo M, Durante A, Tedeschi D, Cortese B, Ielasi A, Valentini G, Tebaldi M, Campo G, Pavasini R, Biscaglia S.

Am J Cardiol. 2023 Sep 19;206:320-329.

Forecasting the Risk of Heart Failure Hospitalization After Acute Coronary Syndromes: the CORALYS HF Score.

D’Ascenzo F, Fabris E, DeGregorio C, Mittone G, De Filippo O, Wojciech W, Leonardi S, Roubin SR, Chinaglia A, Truffa A, Huczek Z, Gaibazzi N, Ielasi A, Cortese B, Borin A, Pagliaro B, Núñez-Gil IJ, Ugo F, Marengo G, Barbieri L, Marchini F, Desperak P, Melendo-Viu M, Montalto C, Bianco M, Bruno F, Mancone M, Ferrandez-Escarabajal M, Morici N, Scaglione M, Tuttolomondo D, Gąsior M, Mazurek M, Gallone G, Campo G, Wojakowski W, Abu Assi E, Stefanini G, Sinagra G, de Ferrari GM.

Catheter Cardiovasc Interv. 2023 Sep 5. doi: 10.1002/ccd.30802.

Impact of diabetes on long-term outcomes of bifurcation percutaneous coronary intervention. An analysis from the BIFURCAT registry.

Bruno F, Kang J, Elia E, Han JK, De Filippo O, Yang HM, Gallone G, Park KW, De Luca L, Kang HJ, Quadri G, Gwon HC, Chun WJ, Giannino G, Hur SH, Han SH, Truffa A, Bin Song Y, Cortese B, Choi KH, Chieffo A, Hong SJ, Di Pietro G, Doh JH, Wanha W, Nam CW, Kim HS, Mattesini A, de De Ferrari GM, Koo BK, D’Ascenzo F.

Cardiovasc Revasc Med. 2023 Aug 31:S1553-8389(23)00797-2.

Clinical outcomes of a dedicated bifurcation stent system.

Sivalingam J, Mazhar MW, Chaddad RA, Fouladvand F, Cortese B.

JACC Cardiovasc Interv. 2023 Aug 14;16(15):1873-1886.

Validation of a Contemporary Acute Kidney Injury Risk Score in Patients With Acute Coronary Syndrome.

Landi A, Chiarito M, Branca M, Frigoli E, Gagnor A, Calabrò P, Briguori C, Andò G, Repetto A, Limbruno U, Sganzerla P, Lupi A, Cortese B, Ausiello A, Ierna S, Esposito G, Ferrante G, Santarelli A, Sardella G, Varbella F, Heg D, Mehran R, Valgimigli M.

JACC Cardiovasc Interv. 2023 Jul 4:S1936-8798(23)00983-4.

Comparison of Outcomes Between 1-Stent and 2-Stent Techniques for Medina Classification 0.0.1 Coronary Bifurcation Lesions. Choi KH, Bruno F, Cho YK, De Luca L, Song YB, Kang J, Mattesini A, Gwon HC, Truffa A, Kim HS, Wańha W, Chun WJ, Gili S, Hur SH, Helft G, Han SH, Cortese B, Lee CH, Escaned J, Yoon HJ, Chieffo A, Hahn JY, Gallone G, Choi SH, De Ferrari G, Koo BK, Quadri G, D’Ascenzo F, Nam CW, de Filippo O.

Minerva Cardiol Angiol. 2023 Aug 4.

Contrast-zero transcatheter aortic valve replacement with ACURATE neo2™ system in patients with severe chronic kidney disease.

Ielasi A, Buono A, Pellicano M, Briguglia D, Uccello G, Cortese B, DE Blasio G, Glauber M, Guagliumi G, Tespili M.

JACC Cardiovasc Interv. 2023 Jul 24;16(14):1794-1803.

Sirolimus-Coated Balloon in an All-Comer Population of Coronary Artery Disease Patients: The EASTBOURNE Prospective Registry.

Cortese B, Testa L, Heang TM, Ielasi A, Bossi I, Latini RA, Lee CY, Perez IS, Milazzo D, Caiazzo G, Tomai F, Benincasa S, Nuruddin AA, Stefanini G, Buccheri D, Seresini G, Singh R, Karavolias G, Cacucci M, Sciahbasi A, Ocaranza R, Menown IBA, Torres A, Sengottvelu G, Zanetti A, Pesenti N, Colombo A; EASTBOURNE Investigators.

J Am Heart Assoc. 2023 Aug;12(15):e028475.

Impact of Complete Revascularization on Development of Heart Failure in Patients With Acute Coronary Syndrome and Multivessel Disease: A Subanalysis of the CORALYS Registry.

Bruno F, Marengo G, De Filippo O, Wanha W, Leonardi S, Raposeiras Roubin S, Fabris E, Popovic M, Giannino G, Truffa A, Huczek Z, Gaibazzi N, Ielasi A, Cortese B, Borin A, Núñez-Gil IJ, Melis D, Ugo F, Bianco M, Barbieri L, Marchini F, Desperak P, Montalto C, Melendo-Viu M, Elia E, Mancone M, Buono A, Ferrandez-Escarabajal M, Morici N, Scaglione M, Tuttolomondo D, Sardella G, Gasior M, Mazurek M, Gallone G, Campo G, Wojakowski W, Abu-Assi E, Sinagra G, De Ferrari GM, D’Ascenzo F; Collaborators.

JACC Cardiovasc Interv. 2023 Jul 24;16(14):1811-1812.

Coronary Sinus Reducer-in-Reducer Implantation in Treating Refractory Angina: A Case Report.

Hamada K, Chaddad R, Fouladvand F, Cortese B.

Cardiovasc Revasc Med. 2023 Jun 6:S1553-8389(23)00628-0.

Design and rationale of a prospective, randomized, non-inferiority trial to determine the safety and efficacy of the Biolimus A9™ drug coated balloon for the treatment of in-stent restenosis: First-in-man trial (REFORM).

Traynor BP, Fitzgerald S, Alfonso F, O’Kane P, Sabaté M, Tölg R, Trevelyan J, Hahn JY, Mylotte D, Wöhrle J, Rai H, Cortese B, Morice MC, Schuette D, Copt S, Oldroyd KG, Byrne RA; REFORM investigators.

Am J Cardiol. 2023 Jul 1;198:1-8.

Coronary Lithotripsy as Elective or Bail-Out Strategy After Rotational Atherectomy in the Rota-Shock Registry.

Sardella G, Stefanini G, Leone PP, Boccuzzi G, Fovero NT, Van Mieghem N, Giacchi G, Escaned J, Fineschi M, Testa L, Valenti R, Di Mario C, Briguori C, Cortese B, Ribichini F, Oreglia JA, Colombo A, Sangiorgi G, Barbato E, Sonck J, Ugo F, Trani C, Castriota F, Paggi A, Porto I, Tomai F, Mancone M.

Catheter Cardiovasc Interv. 2023 May;101(6):1168-1169.

Calcific lesions are the last frontier of endovascular therapies.

Cortese B.

Minerva Cardiol Angiol. 2023 Mar 20.

Coronary stent failure: role of a blended approach with drug-coated balloons for complex lesions.

Cortese B, Sanchez-Jimenez E, Lazar L.

JACC Cardiovasc Interv. 2023 2023 May 8;16(9):1054-1061. 

Long term follow up a RCT of DCB vs EES in small coronary vessels. The PICCOLETO II long term study.

Cortese B, Fernando Alfonso et al..

JAHA. 2023 2023 Mar 21;12(6):e028413. 

Effect of single antiplatelet therapy after DCB angioplasty

Cortese B, Patrick SW.

Front Cardiovasc Med. 2023 Jan 11;9:1064026. 

Patent foramen ovale occlusion with the Cocoon PFO Occluder. The PROS-IT collaborative project.

Testa L, Popolo Rubbio A, Squillace M, Albano F, Cesario V, Casenghi M, Tarantini G, Pagnotta P, Ielasi A, Popusoi G, Paloscia L, Durante A, Maffeo D, Meucci F, Valentini G, Ussia GP, Cioffi P, Cortese B, Sangiorgi G, Contegiacomo G, Bedogni F.

2022

Catheter Cardiovasc Interv. 2022 Dec 16. doi: 10.1002/ccd.30519.

Long-term outcomes following intravascular lithotripsy (IVL) for calcified coronary lesions: A Real-World Multicenter European Study.

Basavarajaiah S, Ielasi A, Raja W, Naneishvili T, Testa L, Popolo Rubbio A, Mastrangelo A, Bartorelli AL, Bhatia G, Choudhury A, Sundara-Raman A, Buono A, Sharma V, Cortese B, Marchesi A, Pitt M, Raju P, Wassef N.

JACC Asia. 2022 Sep 20;2(5):607-618. doi: 10.1016/j.jacasi.2022.05.003.

Impact of Clinical and Lesion Features on Outcomes After Percutaneous Coronary Intervention in Bifurcation Lesions.

Kang J, Bruno F, Rhee TM, De Luca L, Han JK, de Filippo O, Yang HM, Mattesini A, Park KW, Truffa A, Kim HS, Wojciech W, Gwon HC, Gili S, Chun WJ, Helft G, Hur SH, Cortese B, Han SH, Escaned J, Song YB, Chieffo A, Choi KH, Gallone G, Doh JH, De Ferrari G, Hong SJ, Quadri G, Nam CW, Koo BK, D’Ascenzo F.

J Soc Cardiovasc Angiogr Interv. 2022 Dec 5:100551. doi: 10.1016/j.jscai.2022.100551.

“Spontaneous” Coronary Artery Dissection After SARS-CoV-2 Messenger RNA Vaccination.

Mohammed A, Cortese B.

Am J Cardiol. 2022 Oct 31:S0002-9149(22)01062-1.

Utilization of Non-Drug-Eluting Devices for Inpatient Percutaneous Coronary Intervention in the United States.

Sedhom R, Cortese B, Khedr M, Bharadwaj A, Brilakis ES, Pershad A, Basir MB, Alaswad K, Yeh RW, Megaly M.

Minerva Cardiol Angiol. 2022 Nov 2. doi: 10.23736/S2724-5683.22.06181-6. 

The role of optical coherence tomography in guiding percutaneous coronary interventions- is left main the final challenge?

Onea HL, Lazar FL, Olinic DM, Homorodean C, Cortese B.

Int J Cardiol. 2022 Oct 25:S0167-5273(22)01658-8.

IncidenCe and predictOrs of heaRt fAiLure after acute coronarY Syndrome: The CORALYS registry.

De Filippo O, D’Ascenzo F, Wojciech W, Leonardi S, Roubin SR, Fabris E, Truffa A, Huczek Z, Gaibazzi N, Ielasi A, Cortese B, Borin A, Núñez-Gil IJ, Ugo F, Marengo G, Bianco M, Barbieri L, Marchini F, Desperak P, Melendo-Viu M, Montalto C, Bruno F, Mancone M, Ferrandez-Escarabajal M, Morici N, Scaglione M, Tuttolomondo D, Gąsior M, Mazurek M, Gallone G, Campo G, Wojakowski W, Assi EA, Sinagra G, de Ferrari GM.

Catheter Cardiovasc Interv. 2022 Oct 23.

Intravascular imaging for left main stem assessment: An update on the most recent clinical data.

Cortese B, Piraino D, Gentile D, Onea HL, Lazar L.

Front Cardiovasc Med. 2022 Sep 28;9:951882. 

The impact of UEFA Euro 2020 football championship on Takotsubo Syndrome: Results of a multicenter national registry.

Polimeni A, Spaccarotella C, Ielapi J, Esposito G, Ravera A, Martuscelli E, Ciconte V, Menichelli M, Varbella F, Imazio M, Navazio A, Sinagra G, Oberhollenzer R, Sibilio G, Cacciavillani L, Meloni L, Dominici M, Tomai F, Amico F, Corda M, Musumeci G, Lupi A, Zezza L, De Caterina R, Cernetti C, Metra M, Rossi L, Calabrò P, Murrone A, Volpe M, Caldarola P, Carugo S, Cortese B, Valenti R, Boriani G, Fedele F, Ventura G, Manes MT, Colavita AR, Feola M, Versaci F, Assennato P, Arena G, Ceravolo R, Amodeo V, Tortorici G, Nassiacos D, Antonicelli R, Esposito N, Favale S, Licciardello G, Tedesco L, Indolfi C.

J Cardiovasc Med (Hagerstown). 2022 Nov 1;23(11):738-743.

Design of the PERSEO Registry on the management of patients treated with oral anticoagulants and coronary stent.

Sciahbasi A, Gargiulo G, Talarico GP, Cesaro A, Zilio F, De Rosa S, Talanas G, Tebaldi M, Andò G, Rigattieri S, Misuraca L, Cortese B, Imperadore F, Lucci V, Guiducci V, Renda G, Zezza L, Versaci F, Giannico MB, Caruso M, Spaccarotella C, Calabrò P, Esposito G, Tarantini G, Musumeci G, Rubboli A.

Catheter Cardiovasc Interv. 2022 Oct;100(4):544-552.

Sirolimus-coated balloon versus everolimus-eluting stent in de novo coronary artery disease: Rationale and design of the TRANSFORM II randomized clinical trial.

Greco A, Sciahbasi A, Abizaid A, Mehran R, Rigattieri S, de la Torre Hernandez JM, Alfonso F, Cortese B.

Circulation. 2022 Jun 3. doi: 10.1161/CIRCULATIONAHA.122.059635.

Pregnancy and Spontaneous Coronary Artery Dissection: Lessons From Survivors and Nonsurvivors.

Chan N, Premawardhana D, Al-Hussaini A, Wood A, Bountziouka V, Kotecha D, Swahn E, Palmefors H, Pagonis C, Sederholm Lawesson S, Kądziela J, Garcia-Guimarães M, Alfonso F, Escaned J, Macaya F, Santás M, Cerrato E, Maas AHEM, Hlinomaz O, Bogale N, Cortese B, Cheng M, Bolger A, Hussain ST, Samani NJ, Knight M, Cauldwell M, Adlam D.

J Pers Med. 2022 Jun 17;12(6):990.

Prediction of All-Cause Mortality Following Percutaneous Coronary Intervention in Bifurcation Lesions Using Machine Learning Algorithms.

Burrello J, Gallone G, Burrello A, Jahier Pagliari D, Ploumen EH, Iannaccone M, De Luca L, Zocca P, Patti G, Cerrato E, Wojakowski W, Venuti G, De Filippo O, Mattesini A, Ryan N, Helft G, Muscoli S, Kan J, Sheiban I, Parma R, Trabattoni D, Giammaria M, Truffa A, Piroli F, Imori Y, Cortese B, Omedè P, Conrotto F, Chen SL, Escaned J, Buiten RA, Von Birgelen C, Mulatero P, De Ferrari GM, Monticone S, D’Ascenzo F.

J Am Heart Assoc. 2022 Jun 22:e024530.

Aspirin Therapy on Prophylactic Anticoagulation for Patients Hospitalized With COVID-19: A Propensity Score-Matched Cohort Analysis of the HOPE-COVID-19 Registry.

Santoro F, Núñez-Gil IJ, Vitale E, Viana-Llamas MC, Romero R, Maroun Eid C, Feltes Guzman G, Becerra-Muñoz VM, Fernández Rozas I, Uribarri A, Alfonso-Rodriguez E, García Aguado M, Huang J, Castro Mejía AF, Garcia Prieto JF, Elola J, Ugo F, Cerrato E, Signes-Costa J, Raposeiras Roubin S, Jativa Mendez JL, Espejo Paeres C, López Masjuan A, Marin F, Guerra F, El-Battrawy I, Cortese B, Ramakrishna H, Perez-Villacastín J, Fernandez-Ortiz A, Brunetti ND.

-Int J Clin Pract. 2022 May 26;2022:7325060. 

Chronic Oral Anticoagulation Therapy and Prognosis of Patients Admitted to Hospital for COVID-19: Insights from the HOPE COVID-19 Registry.

Rivera-Caravaca JM, Núñez-Gil IJ, Lip GYH, Uribarri A, Viana-Llamas MC, Gonzalez A, Castro-Mejía AF, Alonso González B, Alfonso E, García Prieto JF, Cavallino C, Cortese B, Feltes G, Fernández-Rozas I, Signes-Costa J, Huang J, García Aguado M, Pepe M, Romero R, Cerrato E, Becerra-Muñoz VM, Raposeiras Roubin S, Santoro F, Bagur R, Sposato L, El-Battrawy I, López Masjuan A, Fernandez-Ortiz A, Estrada V, Macaya C, Marín F.

– Korean Circ J. 2022 Jun;52(6):455-459.

Drug-Coated Balloons for Unselected Real World Patients: Are We There Yet?

Alfonso F, Cortese B.

– Cardiovasc Revasc Med. 2022 May 17:S1553-8389(22)00248-2.

Letter to the editor-is FAME 3 trial providing answers or rising more questions?

Lazar FL, Cortese B.

– Minerva Cardiol Angiol. 2022 Apr 14. doi: 10.23736/S2724-5683.22.05989-0.

Which pre-dilatation balloons provide the best lesion preparation prior to use of drug coated balloons in De Novo lesions? Results from the PREPARE study.

Basavarajaiah S, Sharma V, Agip-Fustamante D, Camacho Freire SJ, El-Mokdad R, Bhatia G, Loku Waduge BH, Ielasi A, Díaz Fernández JF, Athukorala S, Cortese B.

– Minerva Cardiol Angiol. 2022 Mar 28. doi: 10.23736/S2724-5683.22.06061-6.

Safety and efficacy of systematic lesion preparation with a novel generation Scoring Balloon in complex percutaneous interventions: results from a prospective registry.

Lazar FL, Ielasi A, Cortese B.

– Minerva Cardiol Angiol. 2022 Mar 25. doi: 10.23736/S2724-5683.22.05997-X.

Balloon aortic valvuloplasty review: the revenge during COVID-19 outbreak?

Cortese B, Sanchez-Jimenez E, Ielasi A, Biccirè F, Budassi S, Prati F, Gelpi G.

– EuroIntervention. 2022 Mar 23:EIJ-D-21-00545.

Coronary lithotripsy for the treatment of underexpanded stents; the international multicentre CRUNCH registry.

Tovar Forero MN, Sardella G, Salvi N, Cortese B, di Palma G, Werner N, Aksoy A, Escaned J, Salazar CH, Gonzalo N, Ugo F, Cavallino C, Sheth TN, Kardys I, Van Mieghem NM, Daemen J.

– JACC Cardiovasc Interv. 2022 Mar 14;15(5):547-549.

Intravascular Imaging for Peripheral Artery Interventions: Ready for Prime Time?

Cortese B, Sanchez-Jimenez E.

– J Cardiovasc Med (Hagerstown). 2022 Apr 1;23(4):278-280.

Three-year results of ST-segment elevation myocardial infarction patients treated with a prespecified bioresorbable vascular scaffold implantation strategy: bVS STEMI STRATEGY-IT long-term.

Moscarella E, Campo G, Leoncini M, Geraci S, Nicolini E, Cortese B, Loi B, Guiducci V, Saccà S, Varricchio A, Vicinelli P, De Candia G, Silvestro A, Calabrò P, Brugaletta S, Latib A, Tespili M, Ielasi A.

– Cardiovasc Revasc Med. 2022 Feb 26:S1553-8389(22)00106-3. doi: 10.1016/j.carrev.2022.02.022. 

Efficacy and safety of a dedicated left atrial appendage occlusion protocol.

Lazar L, Sanchez-Jimenez EF, Cortese B.

– Rev Cardiovasc Med. 2022 Jan 24;23(2):42. doi: 10.31083/j.rcm2302042.

Drug-coated balloon for the management of coronary chronic total occlusions.

Sanchez-Jimenez E, El-Mokdad R, Chaddad R, Cortese B.

– Rev Cardiovasc Med. 2022 Jan 14;23(1):13.

 DCBs as an adjuvant tool to DES for very complex coronary lesions.

Chaddad R, El-Mokdad R, Lazar L, Cortese B.

2021

– Rev Cardiovasc Med. 2021 Dec 22;22(4):1323-1330.

Should paclitaxel be considered an old generation DCB? The limus era.

di Palma G, Sanchez-Jimenez EF, Lazar L, Cortese B.

– Int J Cardiol. 2022 Feb 1;348:47-49.

Excimer laser prior to drug-coated balloon treatment of in-stent restenosis.

Alfonso F, Rivero F, Cortese B.

– J Invasive Cardiol. 2021 Nov;33(11):E890-E899.

Performance of Thin-Strut Stents in Non-Left Main Bifurcation Coronary Lesions: A RAIN Subanalysis.

De Filippo O, D’Ascenzo F, Angelini F, Franchin L, Cerrato E, Pennacchi M, Nuñez-Gil I, Wojakowski W, Imori Y, Trabattoni D, Huczek Z, Venuti G, Muscoli S, Iannaccone M, Montabone A, Marengo G, Rognoni A, Parma R, Figini F, Mitomo S, Boccuzzi G, Mattesini A, Quadri G, Wańha W, Smolka G, Rolfo C, Cortese B, Ryan N, Capodanno D, Chieffo A, di Mario C, Varbella F, Romeo F, Sheiban I, Escaned J, Helft G, De Ferrari GM.

– Eur Heart J Suppl. 2021 Oct 8;23(Suppl E):E63-E67. 

Back to the future: DCB use instead of DES for the treatment of complex, native coronary artery disease.

Cortese B, Sanchez-Jimenez E.

– Med Clin (Engl Ed). 2021 Oct 8;157(7):318-324.

Prognostic factors at admission on patients with cancer and COVID-19: Analysis of HOPE registry data.

Pérez-Segura P, Paz-Cabezas M, Núñez-Gil IJ, Arroyo-Espliguero R, Maroun Eid C, Romero R, Fernández Rozas I, Uribarri A, Becerra-Muñoz VM, García Aguado M, Huang J, Rondano E, Cerrato E, Rodríguez EA, Ortega-Armas ME, Raposeiras Roubin S, Pepe M, Feltes G, Gonzalez A, Cortese B, Buzón L, El-Battrawy I, Estrada V.

– Heart. 2022 Jan;108(2):130-136.

Antiplatelet therapy and outcome in COVID-19: the Health Outcome Predictive Evaluation Registry.

Santoro F, Nuñez-Gil IJ, Vitale E, Viana-Llamas MC, Reche-Martinez B, Romero-Pareja R, Feltez Guzman G, Fernandez Rozas I, Uribarri A, Becerra-Muñoz VM, Alfonso-Rodriguez E, Garcia-Aguado M, Huang J, Ortega-Armas ME, Garcia Prieto JF, Corral Rubio EM, Ugo F, Bianco M, Mulet A, Raposeiras-Roubin S, Jativa Mendez JL, Espejo Paeres C, Albarrán AR, Marín F, Guerra F, Akin I, Cortese B, Ramakrishna H, Macaya C, Fernandez-Ortiz A, Brunetti ND.

-Circ Cardiovasc Interv. 2021 May;14(5):e010013.

RENASCENT III: First in Human Evaluation of the Novel Thin Strut MAGNITUDE Sirolimus-Eluting Ultra-High Molecular Weight MAGNITUDE Bioresorbable Scaffold: 9-Month Imaging and 2-Year Clinical Results.

Ferrone M, Chieffo A, Khawaja SA, Moncada M, Colombo A, Latib A, Esposito G, Stabile E, Avvedimento M, Bedogni F, Testa L, Delgado JA, Arana C, Vesga B, Cortese B, Mahera A, Granada JF.

-Cardiovasc Revasc Med. 2021 Jul;28S:193-196.

Intravascular Lithotripsy and Dual Drug-Coated Balloons for the Treatment of Severely Calcific Renal In-Stent Restenosis: All Is Fair in War.

Di Palma G, Cortese B.

-Med Clin (Barc). 2021 Oct 8;157(7):318-324

Prognostic factors at admission on patients with cancer and COVID-19: Analysis of HOPE registry data.

Pérez-Segura P, Paz-Cabezas M, Núñez-Gil IJ, Arroyo-Espliguero R, Maroun Eid C, Romero R, Fernández Rozas I, Uribarri A, Becerra-Muñoz VM, García Aguado M, Huang J, Rondano E, Cerrato E, Rodríguez EA, Ortega-Armas ME, Raposeiras Roubin S, Pepe M, Feltes G, Gonzalez A, Cortese B, Buzón L, El-Battrawy I, Estrada V.

-Am J Cardiol. 2021 Oct 1;156:72-78.

Long-term (≥15 years) Follow-up of Percutaneous Coronary Intervention of Unprotected Left Main (From the GRAVITY Registry).

D’Ascenzo F, Elia E, Marengo G, Wańha W, Ferreiro RG, Truffa A, Trabattoni D, Figini F, Verardi R, Palma GD, Infusino F, Pivato C, Ochała A, Omedè P, Milewski M, Estevez R, Roubin SR, Filippo O, Conrotto F, Montefusco A, Gili S, Cortese B, Dusi V, Gallone G, Manfredi R, Mancone M, Zoccai GB, Casella G, Templin C, Stefanini G, Wojakowski W, Sheiban I, Ferrari GM.

-Am J Cardiol. 2021 Oct 1;156:16-23.

Benefit of Extended Dual Antiplatelet Therapy Duration in Acute Coronary Syndrome Patients Treated with Drug Eluting Stents for Coronary Bifurcation Lesions (from the BIFURCAT Registry).

De Filippo O, Kang J, Bruno F, Han JK, Saglietto A, Yang HM, Patti G, Park KW, Parma R, Kim HS, De Luca L, Gwon HC, Iannaccone M, Chun WJ, Smolka G, Hur SH, Cerrato E, Han SH, di Mario C, Song YB, Escaned J, Choi KH, Helft G, Doh JH, Truffa Giachet A, Hong SJ, Muscoli S, Nam CW, Gallone G, Capodanno D, Trabattoni D, Imori Y, Dusi V, Cortese B, Montefusco A, Conrotto F, Colonnelli I, Sheiban I, de Ferrari GM, Koo BK, D’Ascenzo F.

-Catheter Cardiovasc Interv. 2021 Sep 28. doi: 10.1002/ccd.29959.

Optical coherence tomography, intravascular ultrasound or angiography guidance for distal left main coronary stenting. The ROCK cohort II study.

Cortese B, de la Torre Hernandez JM, Lanocha M, Ielasi A, Giannini F, Campo G, D’Ascenzo F, Latini RA, Krestianinov O, Alfonso F, Trani C, Prati F, Linares JA, Sardella G, Wlodarczak A, Viganò E, Camarero TG, Stella P, Sozykin A, Fineschi M, Burzotta F.

-Heart. 2021 Oct 5:heartjnl-2021-319552. doi: 10.1136/heartjnl-2021-319552.

Antiplatelet therapy and outcome in COVID-19: the Health Outcome Predictive Evaluation Registry.

Santoro F, Nuñez-Gil IJ, Vitale E, Viana-Llamas MC, Reche-Martinez B, Romero-Pareja R, Feltez Guzman G, Fernandez Rozas I, Uribarri A, Becerra-Muñoz VM, Alfonso-Rodriguez E, Garcia-Aguado M, Huang J, Ortega-Armas ME, Garcia Prieto JF, Corral Rubio EM, Ugo F, Bianco M, Mulet A, Raposeiras-Roubin S, Jativa Mendez JL, Espejo Paeres C, Albarrán AR, Marín F, Guerra F, Akin I, Cortese B, Ramakrishna H, Macaya C, Fernandez-Ortiz A, Brunetti ND.

-Med Clin (Engl Ed). 2021 Oct 8;157(7):318-324.

Prognostic factors at admission on patients with cancer and COVID-19: Analysis of HOPE registry data.

Pérez-Segura P, Paz-Cabezas M, Núñez-Gil IJ, Arroyo-Espliguero R, Maroun Eid C, Romero R, Fernández Rozas I, Uribarri A, Becerra-Muñoz VM, García Aguado M, Huang J, Rondano E, Cerrato E, Rodríguez EA, Ortega-Armas ME, Raposeiras Roubin S, Pepe M, Feltes G, Gonzalez A, Cortese B, Buzón L, El-Battrawy I, Estrada V.

-Eur Heart J Suppl. 2021 Oct 8;23(Suppl E):E63-E67.

Back to the future: DCB use instead of DES for the treatment of complex, native coronary artery disease.

Cortese B, Sanchez-Jimenez E.

-J Invasive Cardiol. 2021 Nov;33(11):E890-E899.

Performance of Thin-Strut Stents in Non-Left Main Bifurcation Coronary Lesions: A RAIN Subanalysis.

De Filippo O, D’Ascenzo F, Angelini F, Franchin L, Cerrato E, Pennacchi M, Nuñez-Gil I, Wojakowski W, Imori Y, Trabattoni D, Huczek Z, Venuti G, Muscoli S, Iannaccone M, Montabone A, Marengo G, Rognoni A, Parma R, Figini F, Mitomo S, Boccuzzi G, Mattesini A, Quadri G, Wańha W, Smolka G, Rolfo C, Cortese B, Ryan N, Capodanno D, Chieffo A, di Mario C, Varbella F, Romeo F, Sheiban I, Escaned J, Helft G, De Ferrari GM.

-Int J Cardiol. 2021 Dec 2:S0167-5273(21)01972-0. 

Excimer laser prior to drug-coated balloon treatment of in-stent restenosis.

Alfonso F, Rivero F, Cortese B.

-Cardiovasc Revasc Med. 2021 Apr 17:S1553-8389(21)00201-3. doi: 10.1016/j.carrev.2021.04.013. 

Cortese B, Caiazzo G, Di Palma G, De Rosa S.

Comparison between sirolimus and paclitaxel-coated balloon for revascularization of coronary arteries. The SIRPAC (SIRolimus-PAClitaxel) study.

-Crit Care Med. 2021 Apr 2. doi: 10.1097/CCM.0000000000005010.

Anticoagulation Therapy in Patients With Coronavirus Disease 2019: Results From a Multicenter International Prospective Registry (Health Outcome Predictive Evaluation for Corona Virus Disease 2019 [HOPE-COVID19]).

Santoro F, Núñez-Gil IJ, Viana-Llamas MC, Maroun Eid C, Romero R, Fernández Rozas I, Parisi A, Becerra-Muñoz VM, García Aguado M, Huang J, Maltese L, Cerrato E, Alfonso-Rodriguez E, Castro Mejía AF, Marin F, Raposeiras Roubin S, Pepe M, Moreno Munguia VH, Feltes G, Navas JV, Cortese B, Buzón L, Liebetrau C, Ramos-Martinez MR, Fernandez-Ortiz A, Estrada V, Brunetti ND.

-Catheter Cardiovasc Interv. 2021 Apr 12. doi: 10.1002/ccd.29677.

Transradial approach for carotid artery stenting: A position paper from the Italian Society of Interventional Cardiology (SICI-GISE).

Montorsi P, Cortese B (joint first Authors), Cernetti C, Lanzellotti D, Di Palma G, Marchese A, Cremonesi A.

-Int J Cardiol. 2021 Mar 29:S0167-5273(21)00567-2.

Impact of COVID-19 pandemic and infection on in hospital survival for patients presenting with acute coronary syndromes: A multicenter registry.

D’Ascenzo F, De Filippo O, Borin A, Barbieri L, Adamo M, Morici N, Truffa Giachet A, Iannaccone M, Crimi G, Gaido L, Bocchino PP, Pivato CA, Campo G, Trabattoni D, Chieffo A, Gaibazzi N, Angelini F, Rubboli A, Rognoni A, Musumeci G, Ugo F, Gili S, Cortese B, Vadalà P, Dusi V, Gallone G, Patti G, de Ferrari GM.

-JACC Cardiovasc Interv. 2021 Mar 22;14(6):710-711.

Reply: Seeking an Appropriate Primary Endpoint for Trials Comparing DCB and DES.

Cortese B, Erriquez A, Alfonso F.

-JACC Cardiovasc Interv. 2021 Mar 22;14(6):702-703.

Is Paclitaxel-Eluting Stent Use Justified by an Adequate Risk Profile?

Cortese B, Fouladvant F.

 -Infection. 2021 Mar 1:1-8. doi: 10.1007/s15010-021-01587-9

COVID-19 anosmia and gustatory symptoms as a prognosis factor: a subanalysis of the HOPE COVID-19 (Health Outcome Predictive Evaluation for COVID-19) registry.

Porta-Etessam J, Núñez-Gil IJ, González García N, Fernandez-Perez C, Viana-Llamas MC, Eid CM, Romero R, Molina M, Uribarri A, Becerra-Muñoz VM, Aguado MG, Huang J, Rondano E, Cerrato E, Alfonso E, Mejía AFC, Marin F, Roubin SR, Pepe M, Feltes G, Maté P, Cortese B, Buzón L, Mendez JJ, Estrada V.

–Minerva Cardioangiol. 2021 Jan 11. doi: 10.23736/S0026-4725.20.05565-6.

Abluminus DES: a step forward in the fight against diabetes?

Asmarats L, Shoeib O, Cortese B.

2020

– JACC Cardiovasc Interv. 2020 Dec 28;13(24):2840-2849.

Drug-Coated Balloon Versus Drug-Eluting Stent for Small Coronary Vessel Disease: PICCOLETO II Randomized Clinical Trial.

Cortese B, Di Palma G, Guimaraes MG, Piraino D, Orrego PS, Buccheri D, Rivero F, Perotto A, Zambelli G, Alfonso F.

-J Invasive Cardiol. 2020 Dec;32(12):E331-E337.

Hard Events AfteR Orsiro Sirolimus-Eluting Stent (HEROES) in STEMI: A Multicenter Registry.

De Marzo V, Parisi R, Caruso M, D’Amario D, Annibali G, Manganiello V, Vergallo R, Donahue M, Cialdella P, Ielasi A, Misuraca L, Altamura L, Cortese B, Larosa C, Canepa M, Porto I.

– J Am Coll Cardiol. 2020 Nov 10;76(19):2235-2237.

Autoimmune Disease and Spontaneous Coronary Artery Dissection: Causation Versus Coexistence.

Adlam D, Cortese B, Kadziela J.

– Cardiovasc Revasc Med. 2020 Oct 17:S1553-8389(20)30651-5. doi: 10.1016/j.carrev.2020.10.004. 

A prospective multicenter randomized trial to assess the effectiveness of the magic touch sirolimus-coated balloon in small vessels: Rationale and design of the TRANSFORM I trial.

Ono M, Kawashima H, Hara H, Katagiri Y, Takahashi K, Kogame N, Wykrzykowska JJ, Piek JJ, Doshi M, Sharif F, Onuma Y, Colombo A, Serruys PW, Cortese B.

-Int J Cardiol. 2021 Jan 1;322:101-102.

Paclitaxel-coated balloons: Are all created equal?

Alfonso F, Del Val D, Cortese B.

– Cardiovasc Revasc Med. 2020 Oct 1:S1553-8389(20)30588-1. 

ImpaCt of an optimal Implantation strategy on Absorb long-term Outcomes: the CIAO Registry.

Rapetto C, Leoncini M, Cerrato E, Regazzoli D, Cortese B, Rossi A, Fetiveau R, Geraci S, De Angelis MC, Tespili M, Iannaccone M, Centola A, Durante A, De Carlo M, De Caterina A, Ribichini F, Favaretto E, Testa L, Pirisi R, Varbella F, Nicolini E, di Palma G, Loi B, Poli A, Caramanno G, Varricchio A, Garbo R, Cuculo A, Petronio AS, Berti S, Bollati M, Spedicato L, De Candia G, Piva T, Quadri G, Colombo A, Ielasi A.

-Catheter Cardiovasc Interv. 2020 Sep 16. doi: 10.1002/ccd.29263

Intravascular lithotripsy in calcified-coronary lesions: A real-world observational, European multicenter study.

Aziz A, Bhatia G, Pitt M, Choudhury A, Hailan A, Upadhyaya S, Lee L, Testa L, Casenghi M, Ielasi A, Cortese B, Rides H, Basavarajaiah S.

-Int J Cardiovasc Imaging. 2020 Aug 10. doi: 10.1007/s10554-020-01957-8.

Prevalence and quantitative assessment of macrophages in coronary plaques.

Gatto L, Paoletti G, Marco V, La Manna A, Fabbiocchi F, Cortese B, Vergallo R, Boi A, Fineschi M, Di Giorgio A, Taglieri N, Calligaris G, Budassi S, Burzotta F, Isidori F, Lella E, Ruscica G, Albertucci M, Tamburino C, Ozaki Y, Alfonso F, Arbustini E, Prati F.

-J Cardiovasc Med (Hagerstown). 2021 Feb 1;22(2):94-100.

Clinical performance of a novel sirolimus-coated balloon in coronary artery disease: EASTBOURNE registry.

Cortese B, Testa L, Di Palma G, Heang TM, Bossi I, Nuruddin AA, Ielasi A, Tespili M, Perez IS, Milazzo D, Benincasa S, Latib A, Cacucci M, Caiazzo G, Seresini G, Tomai F, Ocaranza R, Torres A, Perotto A, Bedogni F, Colombo A.

-J Cardiovasc Med (Hagerstown). 2021 Jan;22(1):20-25.

Impact of stent thickness on clinical outcomes in small vessel and bifurcation lesions: a RAIN-CARDIOGROUP VII sub-study.

Franchin L, Piroli F, D’Ascenzo F, Nuñez-Gil I, Wojakowski W, Imori Y, Trabattoni D, Huczek Z, Venuti G, Muscoli S, Montabone A, Rognoni A, Parma R, Figini F, Mitomo S, Quadri G, Wańha W, Cortese B, De Filippo O, Ryan N, Varbella F, Sheiban I, Helft G, De Ferrari GM.

-Catheter Cardiovasc Interv. 2020 Jul 17. doi: 10.1002/ccd.29113.

Efficacy and safety of intracoronary epinephrine versus conventional treatments alone in STEMI patients with refractory coronary no-reflow during primary PCI: The RESTORE observational study.

Navarese EP, Frediani L, Kandzari DE, Caiazzo G, Cenname AM, Cortese B, Piva T, Muçaj A, Tumscitz C, Paparoni F, Larosa C, Bisceglia T, Menozzi M, Gurbel PA, Kubica J.

-Catheter Cardiovasc Interv. 2020 Jun 27. doi: 10.1002/ccd.29111.

Drug-Coated balloons vs drug-eluting stents for the treatment of small coronary artery disease: A meta-analysis of randomized trials.

Sanz Sánchez J, Chiarito M, Cortese B, Moretti A, Pagnotta P, Reimers B, Stefanini GG, Ferrante G.

-Cardiovasc Revasc Med. 2020 Dec;21(12):1555-1559.

IntravaScular Lithotripsy for the Management of UndILatable Coronary StEnt: The SMILE Registry.

Ielasi A, Moscarella E, Testa L, Gioffrè G, Morabito G, Cortese B, Colangelo S, Tomai F, Arioli F, Maioli M, Leoncini M, Tumminello G, Benedetto S, Lucchina PG, Pennesi M, Ugo F, Viganò E, Bollati M, Missiroli B, Gaspardone A, Calabrò P, Bedogni F, Tespili M.

-Am Heart J. 2020 Jul;225:1-2.

COVID-19 pandemic-Some cardiovascular considerations from the trench.

Cortese B.

-Catheter Cardiovasc Interv. 2020 May 21. doi: 10.1002/ccd.28972.

Accuracy of the PARIS score and PCI complexity to predict ischemic events in patients treated with very thin stents in unprotected left main or coronary bifurcations.

Gallone G, D’Ascenzo F, Conrotto F, Costa F, Capodanno D, Muscoli S, Chieffo A, Yoichi I, Pennacchi M, Quadri G, Nuñez-Gil I, Bocchino PP, Piroli F, De Filippo O, Rolfo C, Wojakowski W, Trabattoni D, Huczek Z, Venuti G, Montabone A, Rognoni A, Parma R, Figini F, Mitomo S, Boccuzzi G, Mattesini A, Cerrato E, Wańha W, Smolka G, Cortese B, Ryan N, Bo M, di Mario C, Varbella F, Burzotta F, Sheiban I, Escaned J, Helft G, De Ferrari GM.

-Catheter Cardiovasc Interv. 2020 Nov;96(5):E565.

How is the cardiovascular patient managed during Covid-19 pandemic? A report from the frontline.

Cortese B.

-Minerva Cardioangiol. 2020 Apr;68(2):134-136.

Contrast-induced acute kidney injury: the long and winding road.

Del Prete A, Della Rocca DG, Versaci F, Cortese B.

-BMC Cardiovasc Disord. 2020 May 15;20(1):225

Comparison of bioresorbable vs durable polymer drug-eluting stents in unprotected left main (from the RAIN-CARDIOGROUP VII Study).

Iannaccone M, Barbero U, De Benedictis M, Imori Y, Quadri G, Trabattoni D, Ryan N, Venuti G, Montabone A, Wojakowski W, Rognoni A, Helft G, Parma R, De Luca L, Autelli M, Boccuzzi G, Mattesini A, Templin C, Cerrato E, Wańha W, Smolka G, Huczek Z, Tomassini F, Cortese B, Capodanno D, Chieffo A, Nuñez-Gil I, Gili S, Bassignana A, di Mario C, Doronzo B, Omedè P, D’Amico M, Tedeschi D, Varbella F, Luscher T, Sheiban I, Escaned J, Rinaldi M, D’Ascenzo F.

-EuroIntervention. 2020 Apr 17;15(17):1479-1482.

Drug-coated balloons for acute myocardial infarction. Ready for prime time?

Alfonso F, Elgendy IY, Cortese B.

-Catheter Cardiovasc Interv. 2020 Nov;96(5):E496-E500

Long-term follow-up after sirolimus-coated balloon use for coronary artery disease. Final results of the Nanolutè study.

El-Mokdad R, di Palma G, Cortese B.

– EuroIntervention. 2020 Jun 12;16(2):e133-e140

First-in-human evaluation of a novel sirolimus-eluting ultra-high molecular weight APTITUDE bioresorbable scaffold: 9- and 24-month imaging and clinical results of the RENASCENT II trial.

Chieffo A, Khawaja SA, Latib A, Vesga B, Moncada M, Delgado JA, Fonseca J, Testa L, Esposito G, Ferrone M, Cortese B, Maehara A, Granada JF, Colombo A; Collaborators.

– Circ Cardiovasc Interv. 2020 Mar;13(3):e008325.

Impact of Kissing Balloon in Patients Treated With Ultrathin Stents for Left Main Lesions and Bifurcations: An Analysis From the RAIN-CARDIOGROUP VII Study.

Gaido L, D’Ascenzo F, Imori Y, Wojakowski W, Saglietto A, Figini F, Mattesini A, Trabattoni D, Rognoni A, Tomassini F, Bernardi A, Ryan N, Muscoli S, Helft G, De Filippo O, Parma R, De Luca L, Ugo F, Cerrato E, Montefusco A, Pennacchi M, Wańha W, Smolka G, de Lio G, Bruno F, Huczek Z, Boccuzzi G, Cortese B, Capodanno D, Omedè P, Mancone M, Nuñez-Gil I, Romeo F, Varbella F, Rinaldi M, Escaned J, Conrotto F, Burzotta F, Chieffo A, Perl L, D’Amico M, di Mario C, Sheiban I, Gagnor A, Giammaria M, De Ferrari GM.

-Catheter Cardiovasc Interv. 2020 Sep 1;96(3):E248-E256

Real-world reasons and outcomes for 1-month versus longer dual antiplatelet therapy strategies with a polymer-free BIOLIMUS A9-coated stent.

Gallone G, D’Ascenzo F, Boccuzzi G, Cortese B, Di Biasi M, Omedè P, Capodanno D, Cerrato E, Vicinelli P, Infantino V, Poli A, Ugo F, Conrotto F, Grigis G, Varbella F, Latini RA, D’Urbano M, Montabone A, Senatore G, Ferrara E, D’Amico M, De Ferrari GM, Ielasi A.

-Am J Cardiol. 2020 Feb 15;125(4):491-499.

Incidence of Adverse Events at 3 Months Versus at 12 Months After Dual Antiplatelet Therapy Cessation in Patients Treated With Thin Stents With Unprotected Left Main or Coronary Bifurcations.

D’Ascenzo F, Barbero U, Abdirashid M, Trabattoni D, Boccuzzi G, Ryan N, Quadri G, Capodanno D, Venuti G, Muscoli S, Tomassini F, Autelli M, Montabone A, Wojakowski W, Rognoni A, Gallo D, Parma R, De Luca L, Figini F, Mitomo S, Montefusco A, Mattesini A, Wańha W, Protasiewicz M, Smolka G, Huczek Z, Rolfo C, Cortese B, Chieffo A, Kuliczowki W, Nuñez-Gil I, Morbiducci U, Ugo F, Marengo G, Iannaccone M, Cerrato E, Mario CD, Moretti C, D’Amico M, Varbella F, Lüscher TF, Sheiban I, Escaned J, Romeo F, Rinaldi M, De Ferrari GM, Helft G.

-Catheter Cardiovasc Interv. 2020 Jul;96(1):1-9.

Impact of structural features of very thin stents implanted in unprotected left main or coronary bifurcations on clinical outcomes.

Iannaccone M, D’Ascenzo F, Gallone G, Mitomo S, Parma R, Trabattoni D, Ryan N, Muscoli S, Venuti G, Montabone A, De Lio F, Zaccaro L, Quadri G, De Filippo O, Wojakowski W, Rognoni A, Helft G, Gallo D, De Luca L, Figini F, Imori Y, Conrotto F, Boccuzzi G, Mattesini A, Wańha W, Smolka G, Huczek Z, Rolfo C, Pennone M, Cortese B, Capodanno D, Chieffo A, Nuñez-Gil I, Morbiducci U, D’Amico M, Varbella F, Romeo F, Sheiban I, Escaned J, Garbo R, Moretti C, di Mario C, De Ferrari GM.

2019

–Am J Cardiol. 2019 Nov 23. pii: S0002-9149(19)31294-9. doi: 10.1016/j.amjcard.2019.10.058. [Epub ahead of print]

Incidence of Adverse Events at 3 Months Versus at 12 Months After Dual Antiplatelet Therapy Cessation in Patients Treated With Thin Stents With Unprotected Left Main or Coronary Bifurcations.

D’Ascenzo F, Barbero U, Abdirashid M, Trabattoni D, Boccuzzi G, Ryan N, Quadri G, Capodanno D, Venuti G, Muscoli S, Tomassini F, Autelli M, Montabone A, Wojakowski W, Rognoni A, Gallo D, Parma R, De Luca L, Figini F, Mitomo S, Montefusco A, Mattesini A, Wańha W, Protasiewicz M, Smolka G, Huczek Z, Rolfo C, Cortese B, Chieffo A, Kuliczowki W, Nuñez-Gil I, Morbiducci U, Ugo F, Marengo G, Iannaccone M, Cerrato E, Mario CD, Moretti C, D’Amico M, Varbella F, Lüscher TF, Sheiban I, Escaned J, Romeo F, Rinaldi M, De Ferrari GM, Helft G.

–JACC Cardiovasc Interv. 2019 Dec 23;12(24):2538-2540. doi: 10.1016/j.jcin.2019.10.044. No abstract available. 

Mortality Increase and Paclitaxel-Coated Device Use: A Plausible But Inconclusive Hypothesis.

Cortese B, Granada JF.

– Egypt Heart J. 2019 Dec 16;71(1):31. doi: 10.1186/s43044-019-0033-z.

The impact of the use of bioresorbable vascular scaffolds and drug-coated balloons in coronary bifurcation lesions.

Elwany M, Zaki A, Latib A, Testa L, Ielasi A, Piraino D, Geraci S, El Zawawy T, Cortese B.

–Minerva Cardioangiol. 2019 Nov 28. doi: 10.23736/S0026-4725.19.05091-6.

The role of optimal lesion preparation for de novo coronary vessels, when a stent-less intervention strategy is planned.

Cortese B.

– Catheter Cardiovasc Interv. 2019 Nov 19. doi: 10.1002/ccd.28600.

The hypothesis of an increased mortality following paclitaxel coated device use in peripheral vascular interventions (and the emerging era of meta-analysis based evidence).

Cortese B, Alfonso F, Pellegrini D, Sing KR, Granada JF.

– Catheter Cardiovasc Interv. 2019 Nov 6. doi: 10.1002/ccd.28584.

Prospective evaluation of drug eluting self-apposing stent for the treatment of unprotected left main coronary artery disease: 1-year results of the TRUNC study.

Briguori C, Tamburino C, Jessurun GAJ, Meyer-Geßner M, Reczuch K, Cortese B, Maillard L, Anthonio RL, La Manna A, Morice MC, Bouchez D, Balland A, Huynh VP, Baumbach A.

– Future Cardiol. 2019 Nov;15(6):437-454. doi: 10.2217/fca-2019-0009. Epub 2019 Nov 5.

Drug-coated balloons for coronary artery disease: current concepts and controversies.

Buccheri D, Lombardo RM, Cortese B.

– Egypt Heart J. 2019 Sep 11;71(1):16. doi: 10.1186/s43044-019-0015-1.

Radial artery perforation: when a friend turns against you.

Elwany M, Latini RA, Di Palma G, Cortese B.

– Coron Artery Dis. 2020 Jan;31(1):27-34. doi: 10.1097/MCA.0000000000000790.

Safety and effectiveness of the self-aPposing, bAlloon-delivered, siRolimus-eluting stent for the Treatment of the coronary Artery disease: SPARTA, a multicenter experience.

Montefusco A, De Filippo O, Gili S, Mancone M, Calcagno S, Cirillo P, Esposito G, Poli A, Ferrara E, Smolka G, Wanha W, Palmieri C, Pastormerlo LE, Baumbach A, Sganzerla P, Tamburino C, Bruno F, Secco GG, Nicolino A, Yew KL, di Palma G, Wojakowski W, Sardella G, Rinaldi M, Cortese B, D’Ascenzo F.

– Catheter Cardiovasc Interv. 2019 Oct 21. doi: 10.1002/ccd.28547.

Role of optical coherence tomography for distal left main stem angioplasty.

Cortese B, Burzotta F, Alfonso F, Pellegrini D, Trani C, Aurigemma C, Rivero F, Antuña P, Orrego PS, Prati F.

– Acta Biomed. 2019 Sep 30;90(10-S):47-49. doi: 10.23750/abm.v90i10-S.8757.

Monogenic hyperlipidemias.

Krasi G, Bushati V, Precone V, Cortese B, Agostini F, Tezzele S, Baglivo M, Cecchin S, Aquilanti B, Velluti V, Matera G, Gagliardi L, Miggiano GAD, Bertelli M.

– Acta Biomed. 2019 Sep 30;90(10-S):20-29. doi: 10.23750/abm.v90i10-S.8751.

Cardiac conduction defects.

Guerri G, Krasi G, Precone V, Paolacci S, Chiurazzi P, Arrigoni L, Cortese B, Dautaj A, Bertelli M.

– Catheter Cardiovasc Interv. 2019 Aug 5. doi: 10.1002/ccd.28413. [Epub ahead of print]

Safety and efficacy of polymer-free biolimus-eluting stents versus ultrathin stents in unprotected left main or coronary bifurcation: A propensity score analysis from the RAIN and CHANCE registries.

D’Ascenzo F, Gaido L, Bernardi A, Saglietto A, Franzé A, Ielasi A, Trabattoni D, Di Biasi M, Infantino V, Rognoni A, Helft G, Gangor A, Latini RA, De Luca L, Mitomo S, Ugo F, Smolka G, Huczek Z, Cortese B, Capodanno D, Chieffo A, Piazza F, di Mario C, Poli A, D’Urbano M, Romeo F, Giammaria M, Varbella F, Sheiban I, Escaned J, De Ferrari GM.

– Int J Cardiol. 2020 Jan 15;299:49-55. doi: 10.1016/j.ijcard.2019.05.067. Epub 2019 Jul 19.

Coronary artery aneurysms, insights from the international coronary artery aneurysm registry (CAAR).

Núñez-Gil IJ, Cerrato E, Bollati M, Nombela-Franco L, Terol B, Alfonso-Rodríguez E, Camacho Freire SJ, Villablanca PA, Amat Santos IJ, de la Torre Hernández JM, Pascual I, Liebetrau C, Camacho B, Pavani M, Albistur J, Latini RA, Varbella F, Jiménez-Díaz VA, Piraino D, Mancone M, Alfonso F, Linares JA, Rodríguez-Olivares R, Jiménez Mazuecos JM, Palazuelos Molinero J, Sánchez-Grande Flecha A, Gomez-Hospital JA, Ielasi A, Lozano Í, Omedè P, Bagur R, Ugo F, Medda M, Louka BF, Kala P, Escaned J, Bautista D, Feltes G, Salinas P, Alkhouli M, Macaya C, Fernández-Ortiz A; CAAR investigators.

– EuroIntervention. 2019 Jul 23. pii: EIJ-D-19-00450. doi: 10.4244/EIJ-D-19-00450. [Epub ahead of print]

Dual antiplatelet therapy strategies and clinical outcomes for a polymer-free biolimus A9-coated stent.

D’Ascenzo F, Gallone G, Boccuzzi G, Cortese B, Di Biasi M, Capodanno D, Vicinelli P, Infantino V, Poli A, Grigis G, Varbella F, De Ferrari GM, Ielasi A; Collaborators.

– Int J Cardiol. 2019 Sep 1;290:21-26. doi: 10.1016/j.ijcard.2019.04.095. Epub 2019 May 3.

Two-year clinical outcomes of the “Italian diffuse/multivessel disease absorb prospective registry” (IT-DISAPPEARS).

De Carlo M, Testa L, Leoncini M, Nicolini E, Varbella F, Cortese B, Ribichini F, Bartorelli AL, Calabria P, Indolfi C, Tomai F, Loi B, Fischietti D, Tarantini G, Bedogni F, Petronio AS.

– Lancet. 2019 May 11;393(10184):1933-1934. doi: 10.1016/S0140-6736(19)30025-X. No abstract available. 

Drug-coated balloons: room for development of BASKET-SMALL 2.

Alfonso F, Guimaraes MG, Rivero F, Cuesta J, Cortese B.

– Cardiovasc Revasc Med. 2019 Apr;20(4):285-286. doi: 10.1016/j.carrev.2019.02.006. No abstract available. 

Paclitaxel Drug-Coated Balloons in Peripheral Artery Disease: Who’s Trying to Shoot the Football Star?

Cortese B, Pellegrini D.

– Future Cardiol. 2019 May;15(3):145-159. doi: 10.2217/fca-2018-0087. Epub 2019 Apr 26.

Focus on STENTYS_® Xposition S Self-Apposing_® stent: a review of available literature.

Pellegrini D, Cortese B.

– J Cardiovasc Med (Hagerstown). 2019 Jul;20(7):471-476. doi: 10.2459/JCM.0000000000000806.

Angiographic performance of a novel sirolimus-coated balloon in native coronary lesions: the FAtebenefratelli SIrolimus COated NATIVES prospective registry.

Cortese B, Pellegrini D, Latini RA, Di Palma G, Perotto A, Orrego PS.

– Int J Cardiol. 2019 Sep 1;290:64-69. doi: 10.1016/j.ijcard.2019.03.038. Epub 2019 Mar 22.

Daily risk of adverse outcomes in patients undergoing complex lesions revascularization: A subgroup analysis from the RAIN-CARDIOGROUP VII study (veRy thin stents for patients with left mAIn or bifurcatioN in real life).

Biolè C, Huczek Z, Nuñez-Gil I, Boccuzzi G, Autelli M, Montefusco A, Trabattoni D, Ryan N, Venuti G, Imori Y, Takano H, Matsuda J, Shimizu W, Muscoli S, Montabone A, Wojakowski W, Rognoni A, Helft G, Gallo D, Parma R, De Luca L, Figini F, Mitomo S, Pennone M, Mattesini A, Templin C, Quadri G, Wańha W, Cerrato E, Smolka G, Protasiewicz M, Kuliczkowski W, Rolfo C, Cortese B, Capodanno D, Chieffo A, Morbiducci U, Iannaccone M, Gili S, di Mario C, D’Amico M, Romeo F, Lüscher TF, Sheiban I, Escaned J, Varbella F, D’Ascenzo F.

– JACC Cardiovasc Interv. 2019 Mar 25;12(6):567-568. doi: 10.1016/j.jcin.2018.12.034. No abstract available. 

Sirolimus-Coated Balloons: A Ferrari for Our Coronary Patients or Another Elegant Town Car?

Cortese B.

– JACC Cardiovasc Imaging. 2019 Dec;12(12):2475-2488. doi: 10.1016/j.jcmg.2019.01.015. Epub 2019 Mar 13.

Spontaneous Coronary Artery Dissection: Pathophysiological Insights From Optical Coherence Tomography.

Jackson R, Al-Hussaini A, Joseph S, van Soest G, Wood A, Macaya F, Gonzalo N, Cade J, Caixeta A, Hlinomaz O, Leinveber P, O’Kane P, García-Guimaraes M, Cortese B, Samani NJ, Escaned J, Alfonso F, Johnson T, Adlam D.

– Am J Cardiol. 2019 May 15;123(10):1610-1619. doi: 10.1016/j.amjcard.2019.02.013. Epub 2019 Feb 23.

Impact of Final Kissing Balloon and of Imaging on Patients Treated on Unprotected Left Main Coronary Artery With Thin-Strut Stents (From the RAIN-CARDIOGROUP VII Study).

D’Ascenzo F, Omedè P, De Filippo O, Cerrato E, Autelli M, Trabattoni D, Ryan N, Venuti G, Muscoli S, Montabone A, Wojakowski W, Rognoni A, Helft G, Gallo D, Parma R, De Luca L, Figini F, Mitomo S, Boccuzzi G, Mattesini A, Wańha W, Smolka G, Huczek Z, Cortese B, Sheiban I, Escaned J, Biolè C, Conrotto F, Templin C, Quadri G, Rolfo C, Capodanno D, Chieffo A, Nuñez-Gil I, Morbiducci U, Iannaccone M, Gili S, Mario CD, Moretti C, D’Amico M, Varbella F, Romeo F, Lüscher TF.

– J Endovasc Ther. 2019 Feb;26(1):41-43. doi: 10.1177/1526602818824682. No abstract available. 

Use of Paclitaxel-Eluting Technologies in the Femoropopliteal Segment Under Scrutiny Over Possible Link to Late All-Cause Mortality: Time to Panic or an Opportunity to Resurge?

Fanelli F, Cortese B, Zeller T.

-EuroIntervention. 2019 May 20;15(1):108-115.

Impact of Absorb bioresorbable scaffold implantation technique on post-procedural quantitative coronary angiographic endpoints in ST-elevation myocardial infarction: a sub-analysis of the BVS STEMI STRATEGY-IT study.

Hioki H, Brugaletta S, Ishida K, Campo G, Biscaglia S, Ortega-Paz L, Cortese B, Varricchio A, Latib A, Sabaté M, Tespili M, Ielasi A. 

2018

-Catheter Cardiovasc Interv. 2018 Oct 22. doi: 10.1002/ccd.27845. [Epub ahead of print]

One-year clinical performance of ABSORB bioresorbable vascular scaffold in patients presenting with acute coronary syndromes: Results from the RAI registry.

Moscarella E, Ielasi A, Varricchio A, Cortese B, Loi B, Tarantini G, Pisano F, Durante A, Pasquetto G, Colombo A, Tumminello G, Moretti L, Calabrò P, Mazzarotto P, Tespili M, Silva Orrego P, Corrado D, Steffenino G; RAI Investigators.

-Cardiovasc Revasc Med. 2018 Oct 4. pii: S1553-8389(18)30442-1. doi: 10.1016/j.carrev.2018.10.003.

One-year results following a pre-specified ABSORB implantation strategy in ST-elevation myocardial infarction (BVS STEMI STRATEGY-IT study).

Ielasi A, Campo G, Cortese B, Leoncini M, Varricchio A, Brugaletta S, Favaretto E, Fineschi M, Piraino D, Calabria P, Granata F, Pisano F, Mussardo M, Latib A, Tespili M.

-Catheter Cardiovasc Interv. 2018 Oct 8. doi: 10.1002/ccd.27809.

Self-expandable sirolimus-eluting stents compared to second-generation drug-eluting stents for the treatment of the left main: A propensity score analysis from the SPARTA and the FAILS-2 registries.

Montefusco A, D’Ascenzo F, Gili S, Smolka G, Chieffo A, Baumbach A, Escaned J, Sganzerla P, Tomassini F, Secco GG, Ugo F, Tamburino C, Nicolino A, Mancone M, Poli A, Yew KL, Cirillo P, Wanha W, Pastormerlo LE, di Summa R, Sardella G, Colombo A, Gaita F, Cortese B.

-Cardiovasc Revasc Med. 2018 Jun 28. pii: S1553-8389(18)30246-X. doi: 10.1016/j.carrev.2018.06.003

A novel nanocarrier sirolimus-coated balloon for coronary interventions: 12-Month data from the Nanoluté Registry.

Dani S, Shah D, Sojitra P, Parikh K, Shetty R, di Palma G, Cortese B.

-Lancet. 2018 Sep 8;392(10150):835-848. doi: 10.1016/S0140-6736(18)31714-8

Radial versus femoral access and bivalirudin versus unfractionated heparin in invasively managed patients with acute coronary syndrome (MATRIX): final 1-year results of a multicentre, randomised controlled trial.

Valgimigli M, Frigoli E, Leonardi S, Vranckx P, Rothenbühler M, Tebaldi M, Varbella F, Calabrò P, Garducci S, Rubartelli P, Briguori C, Andó G, Ferrario M, Limbruno U, Garbo R, Sganzerla P, Russo F, Nazzaro M, Lupi A, Cortese B, Ausiello A, Ierna S, Esposito G, Ferrante G, Santarelli A, Sardella G, de Cesare N, Tosi P, van ‘t Hof A, Omerovic E, Brugaletta S, Windecker S, Heg D, Jüni P; MATRIX Investigators.

-JACC Cardiovasc Interv. 2018 Jul 23;11(14):1418-1419. doi: 10.1016/j.jcin.2018.03.041.

Does Late Lumen Loss Represent a Measure of the Efficacy of Bioresorbable Scaffolds?

Cortese B.

-EuroIntervention. 2018 Jul 10

“Coronary artery treatment with an urea-based paclitaxel-coated balloon: The European wide Falcon all comers DCB Registry (FALCON-Registry).“

Widder JD, Cortese B, Levesque S, Berliner D, Eccleshall S, Graf K, Doutrelant L, Ahmed J, Bressollette E, Zavalloni D, Piraino D, Roguin A, Scheller B, Stella PR, Bauersachs J.

-Int J Cardiol. 2018 Sep 1;266:67-74. 

“Full-plastic jacket” with everolimus-eluting Absorb bioresorbable vascular scaffolds: Clinical outcomes in the multicenter prospective RAI registry (ClinicalTrials.gov Identifier: NCT02298413).

Tarantini G, Masiero G, Fovino LN, Mojoli M, Varricchio A, Loi B, Gistri R, Misuraca L, Gabrielli G, Cortese B, Pisano F, Moretti L, Tumminello G, Olivari Z, Mazzarotto P, Colombo A, Calabrò P, Nicolino A, Tellaroli P, Corrado D, Durante A, Steffenino G; all RAI investigators.

-JACC Cardiovasc Interv. 2018 May 28;11(10):967-968. doi: 10.1016/j.jcin.2018.04.024. 

“Paclitaxel-Eluting Stents and Aneurysm Formation, A Worrisome Association.“

Cortese B.

-Cardiovasc Revasc Med. 2018 Apr 4. pii: S1553-8389(18)30094-0. doi: 10.1016/j.carrev.2018.03.005

“Clinical performance of a dedicated self-apposing stent for the treatment of left main stem disease. Results of the left Main AngioplasTy wIth a Self-apposing StEnt – the MATISSE study.“

Cortese B, Montefusco A, D’Ascenzo F, La Manna A, Andò G, Bisceglia T, Secco GG, Meyer-Gessner M, Wojciech W, Sganzerla P, Napodano M, Di Palma G, Latini RA, Tamburino C, Orrego PS, Baumbach A.

-Egypt Heart J. 2018 Mar;70(1):55-56. doi: 10.1016/j.ehj.2017.12.006. Epub 2017 Dec 28

“Long-term efficacy of drug-coated balloon for renal artery in-stent restenosis.“

Elwany M, Di Palma G, Cortese B.

– J Am Coll Cardiol. 2018 Mar 20;71(11):1231-1242. doi: 10.1016/j.jacc.2018.01.033.

“Bivalirudin or Heparin in Patients Undergoing Invasive Management of Acute Coronary Syndromes.“

Gargiulo G, Carrara G, Frigoli E, Vranckx P, Leonardi S, Ciociano N, Campo G, Varbella F, Calabrò P, Garducci S, Iannone A, Briguori C, Andò G, Crimi G, Limbruno U, Garbo R, Sganzerla P, Russo F, Lupi A, Cortese B, Ausiello A, Ierna S, Esposito G, Zavalloni D, Santarelli A, Sardella G, Tresoldi S, de Cesare N, Sciahbasi A, Zingarelli A, Tosi P, van ‘t Hof A, Omerovic E, Brugaletta S, Windecker S, Valgimigli M.

– G Ital Cardiol (Rome). 2018 Feb;19(2):77-80. doi: 10.1714/2868.28938. 

PCSK9 inhibitors: how to bridge the gap between scientific evidence and regulatory barriers?

Cortese B, Di Palma G, Lettieri C, Musumeci G.

-Catheter Cardiovasc Interv. 2018 Mar 7. doi: 10.1002/ccd.27522.

Absorb bioresorbable vascular scaffold vs. everolimus-eluting metallic stent in small vessel disease: A propensity matched analysis of COMPARE II, RAI, and MAASSTAD-ABSORB studies.

Tarantini G, Masiero G, Barioli A, Paradies V, Vlachojannis G, Tellaroli P, Cortese B, di Palma G, Varricchio A, Ielasi A, Loi B, Steffenino G, Ueshima D, Mojoli M, Smits P.

-Heart Lung Circ. 2018 Feb 9. pii: S1443-9506(18)30029-5. doi: 10.1016/j.hlc.2017.07.014.

“Coronary Artery Fistulae: Anatomy, Diagnosis and Management Strategies.“

Buccheri D, Chirco PR, Geraci S, Caramanno G, Cortese B.

– Catheter Cardiovasc Interv. 2018 Feb 26. doi: 10.1002/ccd.27549.

“Coronary sinus perforation during reducer implantation.“

Cortese B, di Palma G, Latini R.

– Minerva Cardioangiol. 2018 Feb 19. doi: 10.23736/S0026-4725.18.04641-8.

“Magic Touch: preliminary clinical evidence with a novel Sirolimus drug coated balloon.“

Cortese B, DI Palma G, Latini R.

– J Cardiovasc Med (Hagerstown). 2018 May;19(5):247-252.

Treatment of coronary artery disease with a new-generation drug-coated balloon: final results of the Italian Elutax SV rEgistry-DCB-RISE.

Cortese B, D’Ascenzo F, Fetiveau R, Balian V, Blengino S, Fineschi M, Rogacka R, Lettieri C, Pavei A, D’Amico M, Poli A, Di Palma G, Latini RA, Orrego PS, Seregni R.

– Int J Cardiol. 2018 May 1;258:50-54. doi: 10.1016/j.ijcard.2018.01.135.

“Clinical findings after bioresorbable vascular scaffold implantation in an unrestricted cohort of patients with ST-segment elevation myocardial infarction (from the RAI registry).“

Moscarella E, Ielasi A, Varricchio A, De Angelis MC, Loi B, Tarantini G, Calabrò P, Cortese B, Mazzarotto P, Gabrielli G, Pisano F, Facchin M, Misuraca L, Lucci V, Gistri R, Tumminello G, Moretti L, Colombo A, Durante A, Fineschi M, Piraino D, Ferrario M, Coscarelli S, Nicolino A, Tespili M, Corrado D, Steffenino G.

-Am Heart J. 2018 Feb;196:113-118. doi: 10.1016/j.ahj.2017.10.014.

“Determinants of radiation dose during right transradial access: Insights from the RAD-MATRIX study.“

Sciahbasi A, Frigoli E, Sarandrea A, Calabrò P, Rubartelli P, Cortese B, Tomassini F, Zavalloni D, Tebaldi M, Calabria P, Rigattieri S, Zingarelli A, Sardella G, Lupi A, Rothenbühler M, Heg D, Valgimigli M.

-Future Cardiol. 2018 Mar;14(2):165-179. doi: 10.2217/fca-2017-0068.

“Treatment of coronary bifurcation lesions: current knowledge and future perspectives.“

Elwany M, Palma GD, Cortese B.

– Catheter Cardiovasc Interv. 2018 Jan 22. doi: 10.1002/ccd.27473.

“Bioresorbable vascular scaffold versus everolimus-eluting stents or drug eluting balloon for the treatment of coronary in-stent restenosis: 1-Year follow-up of a propensity score matching comparison (the BIORESOLVE-ISR Study).“

Moscarella E, Tanaka A, Ielasi A, Cortese B, Coscarelli S, De Angelis MC, Piraino D, Latib A, Grigis G, Bianchi R, Buccheri D, Calabrò P, Tespili M, Silva Orrego P, Colombo A, Varricchio A.

-JACC Cardiovasc Interv. 2018 Jan 8;11(1):36-50.

“Impact of Sex on Comparative Outcomes of Radial Versus Femoral Access in Patients With Acute Coronary Syndromes Undergoing Invasive Management: Data From the Randomized MATRIX-Access Trial.“

Gargiulo G, Ariotti S, Vranckx P, Leonardi S, Frigoli E, Ciociano N, Tumscitz C, Tomassini F, Calabrò P, Garducci S, Crimi G, Andò G, Ferrario M, Limbruno U, Cortese B, Sganzerla P, Lupi A, Russo F, Garbo R, Ausiello A, Zavalloni D, Sardella G, Esposito G, Santarelli A, Tresoldi S, Nazzaro MS, Zingarelli A, Petronio AS, Windecker S, da Costa BR, Valgimigli M.

2017

-Cardiovasc Revasc Med. 2017 Nov 10. pii: S1553-8389(17)30407-4.

“Left-main restenosis in the DES era-a call for action.“

Di Palma G, Cortese B.

-EuroIntervention. 2017 Oct 3. pii: EIJ-D-17-00443. doi: 10.4244/EIJ-D-17-00443.

“One-Year Clinical Outcomes After Unrestricted Implantation of Absorb Bioresorbable Scaffold (RAI Registry).“

Ielasi A, Cortese B, Moscarella E, Loi B, Tarantini G, Varricchio A, Pisano F, Durante A, Pasquetto G, Colombo A, Tumminello G, Moretti L, Calabrò P, Mazzarotto P, Tespili M, Corrado D, Steffenino G.

-JACC Cardiovasc Interv. 2017 Sep 25;10(18):1855-1864. doi: 10.1016/j.jcin.2017.07.023.

“A Prospective Evaluation of a Pre-Specified Absorb BVS Implantation Strategy in ST-Segment Elevation Myocardial Infarction: The BVS STEMI STRATEGY-IT Study.“

Ielasi A, Campo G, Rapetto C, Varricchio A, Cortese B, Brugaletta S, Geraci S, Vicinelli P, Scotto di Uccio F, Secco GG, Poli A, Nicolini E, Ishida K, Latib A, Tespili M.

-JACC Cardiovasc Interv. 2017 Sep 25;10(18):1809-1815. doi: 10.1016/j.jcin.2017.06.067.

“Clinical, Angiographic, and Procedural Correlates of Acute, Subacute, and Late Absorb Scaffold Thrombosis.“

Ellis SG, Steffenino G, Kereiakes DJ, Stone GW, van Geuns RJ, Abizaid A, Nef H, Cortese B, Testa L, Menichelli M, Tamburino C, Gori T, Kimura T, Serruys PW, Brugaletta S, Sabaté M, Gao RL.

-Cardiovasc Revasc Med. 2017 Aug 12. pii: S1553-8389(17)30259-2. doi: 10.1016/j.carrev.2017.08.001. [Epub ahead of print]

“Novel paclitaxel-coated scoring ballon for de novo complex coronary lesions-first report.“

di Palma G, Cortese B.

-J Thorac Dis. 2017 Aug;9(Suppl 9):S935-S939. doi: 10.21037/jtd.2017.06.82. Review.

“Occurrence and management of bioresorbable vascular scaffold failure in real-life studies.“

Cortese B, Elwany M.

-Coron Artery Dis. 2017 Aug;28(5):437-439. doi: 10.1097/MCA.0000000000000505.

“First-in-man demonstration of complete bioresorbable vascular scaffold resorption after treatment of in-stent restenosis.“

Moscarella E, Ielasi A, Cortese B, De Angelis MC, Varricchio A.

-J Am Coll Cardiol. 2017 May 11. pii: S0735-1097(17)36897-3. doi: 10.1016/j.jacc.2017.02.070.

“Acute Kidney Injury After Radial or Femoral Access for Invasive Acute Coronary Syndrome Management: AKI-MATRIX.“

Andò G, Cortese B, Russo F, Rothenbühler M, Frigoli E, Gargiulo G, Briguori C, Vranckx P, Leonardi S, Guiducci V, Belloni F, Ferrari F, de la Torre Hernandez JM, Curello S, Liistro F, Perkan A, De Servi S, Casu G, Dellavalle A, Fischetti D, Micari A, Loi B, Mangiacapra F, Russo N, Tarantino F, Saia F, Heg D, Windecker S, Jüni P, Valgimigli M; MATRIX Investigators.

-JACC Cardiovasc Interv. 2017 Jul 24;10(14):1469-1471. doi: 10.1016/j.jcin.2017.05.039.

“Pulse on Spontaneous Coronary Artery Dissections: Experience-Based Survey.“

Buccheri D, Zambelli G, Alfonso F, Cortese B.

-J Endovasc Ther. 2017 Feb;24(1):169.

 “True Competitor of Femoral Access for Iliac Endovascular Interventions.“

Elwany M, Di Palma G, Cortese B.

-J Interv Cardiol. 2017 Aug 29. doi: 10.1111/joic.12415.

“Clinical and angiographic outcome of a single center, real world population treated with a dedicated technique of implantation for bioresorbable vascular scaffolds. The FAtebenefratelli Bioresorbable Vascular Scaffold (FABS) registry.“

Cortese B, di Palma G, Dendramis G, Cerrato E, Latini RA, Elwany M, Orrego PS, Seregni RG.

-Catheter Cardiovasc Interv. 2017 May 22. doi: 10.1002/ccd.26957. [Epub ahead of print]

Elwany M, Di Palma G, Cortese B.

“Drug-coated balloons for the treatment of in-stent restenosis in diabetic patients: A review of currently available scientific data.“

Minacapelli A, Piraino D, Buccheri D, Cortese B.

-EuroIntervention. 2017 Aug 4;13(5):e540-e548. doi: 10.4244/EIJ-D-17-00307.

“Bivalirudin infusion to reduce ventricular infarction: the open-label, randomised Bivalirudin Infusion for Ventricular InfArction Limitation (BIVAL) study.“

van Geuns RJ, Sideris G, Van Royen N, El Mahmoud R, Diletti R, Bal Dit Sollier C, Garot J, Van Der Hoeven NW, Cortese B, Ding L, Lechthaler I, Deliargyris EN, Anthopoulos P, Drouet L.

-Catheter Cardiovasc Interv. 2017 May 13. doi: 10.1002/ccd.27095. [Epub ahead of print]

“Clinical outcomes of overlapping versus non-overlapping everolimus-eluting absorb bioresorbable vascular scaffolds: An analysis from the multicentre prospective RAI registry (ClinicalTrials.gov identifier: NCT02298413).“

Tarantini G, Mojoli M, Masiero G, Cortese B, Loi B, Varricchio A, Gabrielli G, Durante A, Pasquetto G, Calabrò P, Gistri R, Tumminello G, Misuraca L, Pisano F, Ielasi A, Mazzarotto P, Coscarelli S, Lucci V, Moretti L, Nicolino A, Colombo A, Olivari Z, Fineschi M, Piraino D, Piatti L, Canosi U, Tellaroli P, Corrado D, Rovera C, Steffenino G; all RAI investigators.

-EuroIntervention. 2017 Jul 20;13(4):424-431. doi: 10.4244/EIJ-D-17-00246.

“One-year clinical results of the Italian diffuse/multivessel disease ABSORB prospective registry (IT-DISAPPEARS).“

Testa L, De Carlo M, Petrolini A, Rapetto C, Varbella F, Cortese B, Gabrielli G, Geraci S, Loi B, Boccuzzi G, Tarantini G, Fischetti D, Calabria P, Tomai F, Ribichini F, Tamburino C, Indolfi C, Bartorelli AL, Petronio AS, Bedogni F.

-Coron Artery Dis. 2017 Aug;28(5):437-439. doi: 10.1097/MCA.0000000000000505. No abstract available. 

“First-in-man demonstration of complete bioresorbable vascular scaffold resorption after treatment of in-stent restenosis.“

Moscarella E, Ielasi A, Cortese B, De Angelis MC, Varricchio A.

-Heart Lung Circ. 2017 Mar 3. pii: S1443-9506(17)30083-5. doi: 10.1016/j.hlc.2017.01.018.

“Drug-Eluting Balloon In-Stent Restenosis Treatment: Why not?“

Buccheri D, Cortese B.

-Catheter Cardiovasc Interv. 2017 Mar 15. doi: 10.1002/ccd.26995. [Epub ahead of print]

“Fracture with the newer bioresorbable vascular scaffolds.“

Elwany M, Di Palma G, Cortese B.

-Cardiovasc Revasc Med. 2017 Mar 8. pii: S1553-8389(17)30066-0. doi: 10.1016/j.carrev.2017.03.007. [Epub ahead of print]

“A hybrid strategy with bioresorbable vascular scaffolds and drug eluting stents for treating complex coronary lesions.“

Jabbour RJ, Ielasi A, Tanaka A, Leoncini M, Cortese B, Grigis G, Mitomo S, Regazzoli D, Di Palma G, Rapetto C, Tespili M, Colombo A, Latib A.

-J Am Coll Cardiol. 2017 Mar 15. pii: S0735-1097(17)36042-4. doi: 10.1016/j.jacc.2017.03.018. [Epub ahead of print]

“Radiation Exposure and Vascular Access in Acute Coronary Syndromes: The RADMatrix Trial.“

Sciahbasi A, Frigoli E, Sarandrea A, Rothenbühler M, Calabrò P, Lupi A, Tomassini F, Cortese B, Rigattieri S, Cerrato E, Zavalloni D, Zingarelli A, Calabria P, Rubartelli P, Sardella G, Tebaldi M, Windecker S, Jüni P, Heg D, Valgimigli M.

-Cardiovasc Revasc Med. 2017 Mar 25. pii: S1553-8389(17)30109-4. doi: 10.1016/j.carrev.2017.03.025. [Epub ahead of print]

“Immediate and short-term performance of a novel sirolimus-coated balloon during complex percutaneous coronary interventions. The FAtebenefratelli SIrolimus COated-balloon (FASICO) registry.“

Cortese B, di Palma G, Latini RA, Elwany M, Orrego PS, Seregni RG.

-JACC Cardiovasc Interv. 2017 Apr 10;10(7):743-745. doi: 10.1016/j.jcin.2017.01.038. 

“Bioresorbable Vascular Scaffolds as a Treatment Option for Left Main Lesions.“

Jabbour RJ, Tanaka A, Capranzano P, Cortese B, Lesiak M, Testa L, Gatto P, Suarez de Lezo J, Mattesini A, Geraci S, Ielasi A, Diletti R, Capodanno D, Buccheri D, Iwanczyk S, Bedogni F, Tchetche D, Di Mario C, Caramanno G, Van Mieghem NM, Tamburino C, Colombo A, Latib A.

-Cardiovasc Revasc Med. 2017 Mar 25. pii: S1553-8389(17)30104-5. doi: 10.1016/j.carrev.2017.03.020. [Epub ahead of print]

“First experience of drug-coated balloons for treatment of bioresorbable vascular scaffold restenosis.“

Elwany M, Latini RA, Di Palma G, Orrego PS, Cortese B.

-G Ital Cardiol (Rome). 2017 Feb;18(2 Suppl 1):22S-30S. doi: 10.1714/2657.27245. Italian.

“New technologies and applications for drug-coated balloons.“

Cortese B, Di Palma G, Nerla R, Micari A.

-Am J Cardiol. 2017 Jun 15;119(12):1924-1930

“Thirty-Day Outcomes After Unrestricted Implantation of Bioresorbable Vascular Scaffold (from the Prospective RAI Registry).“

Cortese B, Ielasi A, Moscarella E, Loi B, Tarantini G, Pisano F, Durante A, Pasquetto G, Colombo A, Tumminello G, Moretti L, Calabrò P, Mazzarotto P, Varricchio A, Tespili M, Latini RA, Defilippi G, Corrado D, Steffenino G; RAI Investigators..

-J Thorac Dis. 2017 Mar;9(3):417-418. doi: 10.21037/jtd.2017.03.05.

“Should we reconsider dual antiplatelet therapy duration following bioresorbable scaffold angioplasty?“

Buccheri D, Caramanno G, Geraci S, Cortese B.

Catheter Cardiovasc Interv. 2017 May 2. doi: 10.1002/ccd.27087. [Epub ahead of print]

“Transradial versus transfemoral ancillary approach in complex structural, coronary, and peripheral interventions. Results from the multicenter ancillary registry: A study of the Italian Radial Club.“

Cortese B, Rigattieri S, Aranzulla TC, Russo F, Latib A, Burzotta F, Agostoni P, Ielasi A, Tarantino F, Sticchi A, Di Palma G, de Benedictis M, Trani C, Boccaletti R, Miccoli R, Valsecchi O, Colombo A.

-J Am Coll Cardiol. 2017 Jan 17;69(2):176-185. doi: 10.1016/j.jacc.2016.10.055.

“Cangrelor With and Without Glycoprotein IIb/IIIa Inhibitors in Patients Undergoing Percutaneous Coronary Intervention.”

Vaduganathan M, Harrington RA, Stone GW, Deliargyris EN, Steg PG, Gibson CM, Hamm CW, Price MJ, Menozzi A, Prats J, Elkin S, Mahaffey KW, White HD, Bhatt DL; CHAMPION Investigators.

-Int J Cardiol. 2017 Mar 1;230:91-96.

“Recurrent in-stent restenosis, certainty of its origin, uncertainty about treatment.”

Piraino D, Cimino G, Buccheri D, Dendramis G, Andolina G, Cortese B.

2016

-J Am Coll Cardiol. 2016 Nov 1;68(18S):B176. doi: 10.1016/j.jacc.2016.09.572.

“Clinical outcome of coronary bifurcation management with a “fully bioresorbable” technique. Results of the multicentre BBS study.”

Cortese B, Latib A, Piraino D, Testa L, Ielasi A, Geraci S, Tanaka A, Buccheri D, Latini RA, Silva Orrego PL, Seregni RG,Colombo A.

-J Am Coll Cardiol. 2016 Nov 1;68(18S):B171-B172. doi: 10.1016/j.jacc.2016.09.560.

“Bioresorbable vascular scaffold technology for small vessel coronary artery disease: results from the Italian multicenter RAI Registry.”

Masiero G, Tarantini G, Mojoli M, Loi B, Cortese B, Varricchio A, Ielasi A, Pisano F, Mazzarotto P, Calabro’ P, Gistri R, Durante A, Piraino D, Tumminello G, Lucci V, Moretti L, Misuraca L, Pasquetto G, Colombo A, Ferrario M, Coscarelli S, Olivari Z, Nicolino A, Piatti L, Tellaroli P, Seregni RG, Corrado D, Steffenino G.

-J Am Coll Cardiol. 2016 Nov 1;68(18S):B168-B169. doi: 10.1016/j.jacc.2016.09.552.

“Bioresorbable vascular scaffold in chronic total coronary artery occlusions: results from the RAI registry.”

Loi B, Cortese B, Sanna F, Tarantini G, Ielasi A, Fineschi M, Calzolari D, Gabrielli G, Durante A, Pisano F, Varricchio A, Moretti L, Corrado D, Steffenino G.

-J Am Coll Cardiol. 2016 Nov 1;68(18S):B165-B166. doi: 10.1016/j.jacc.2016.09.543.

Thirty-day Outcome Following Polymeric Bioresorbable Scaffold Implantation in 347 STEMI Patients Enrolled in the Multicenter “Registro Absorb Italiano” (RAI Registry).

Ielasi A, Moscarella E, Loi B, Cortese B, Calabro’ P, Tarantini G, Gistri R, Pisano F, Mazzarotto P, Gabrielli G, Pasquetto G, Misuraca L, Lucci V, Tumminello G, Moretti L, Ferrario M, Colombo A, Durante A, Fineschi M, Nicolino A, Piraino D, Varricchio A, Seregni RG, Tespili M, Corrado D, Steffenino G.

-J Am Coll Cardiol. 2016 Nov 1;68(18S):B157. doi: 10.1016/j.jacc.2016.09.522.

Sirolimus Coated Balloons for the Prevention of Vascular Restenosis in small vessel disease: Insights from the Nanoluté Registry.

Chodvadiya P, Cortese B.

– J Thorac Dis. 2016 Oct;8(10):E1150-E1162

Understanding and managing in-stent restenosis: a review of clinical data, from pathogenesis to treatment.

Buccheri D, Piraino D, Andolina G, Cortese B.

-Int J Cardiol. 2017; 228:209-213

 Final shape of biovascular scaffolds and clinical outcome. Results from a multicenter all-comers study with intravascular imaging.

Cortese B, Piraino D, Latini RA, Zavalloni D, Ielasi A, Agostoni P, Mazzarotto P, Tespili M, Seregni R.

-Catheter Cardiovasc Interv. 2016 Oct 24. doi: 10.1002/ccd.26801.

A prospective evaluation of a standardized strategy for the use of a polymeric everolimus-eluting bioresorbable scaffold in ST-segment elevation myocardial infarction: Rationale and design of the BVS STEMI STRATEGY-IT study.

Ielasi A, Varricchio A, Campo G, Leoncini M, Cortese B, Vicinelli P, Brugaletta S, di Uccio FS, Latib A, Tespili M.

-Int J Cardiol. 2016 Dec 1;224:335-336.

Acutely malapposed bioresorbable vascular scaffold during primary angioplasty for spontaneous coronary artery dissection: Is a no-metal strategy better?

Cortese B, Buccheri D.

-G Ital Cardiol (Rome). 2016 Oct;17(10):28-44. doi: 10.1714/2372.25480. Italian.

SICI-GISE Position paper: Use of Absorb BVS in clinical practice

Tarantini G, Saia F, Capranzano P, Cortese B, Mojoli M, Boccuzzi G, Cuculo A, Geraci S, Mattesini A, Oreglia J, Summaria F, Testa L, Berti S, Esposito G, La Manna A, Limbruno U, Marchese A, Mauro C, Tarantino F, Salvi A, Santoro G, Varbella F, Violini R, Musumeci G.

– Expert Opin Drug Deliv. 2016 Oct 8.

Alfonso F, García-Guimarães M, Navarrete G, Cuesta J, Bastante T, Benedicto A, Rivero F, Cortese B.

Drug-eluting balloons in coronary interventions: The quiet revolution?

– British Medical Journal 2016;354:i4935

Bivalirudin or unfractionated heparin in patients with acute coronary syndromes managed invasively with and without ST elevation (MATRIX): randomised controlled trial

Leonardi S, Frigoli E, Rothenbühler M, Navarese E,  Calabró P, Bellotti P,  Briguori C,  Ferlini M, Cortese B,  …, Valgimigli M. Matrix Investigators.

– Int J Cardiol. 2016 Sep 17;224:335-336.

Acutely malapposed bioresorbable vascular scaffold during primary angioplasty for spontaneous coronary artery dissection: Is a no-metal strategy better?

Cortese B, Buccheri D.

– Catheter Cardiovasc Interv. 2016 Sep 21.

First reported use of drug-coated balloon for bioresorbable in-scaffold restenosis.

Latini RA, Buccheri D, Cortese B.

-EuroIntervention. 2016 Aug 20;12(6):759

Left main stem angioplasty without metal: a new paradigm in interventional cardiology?

Cortese B, Piraino D, Galfrascoli E, Silva Orrego P, Seregni RG

– Am J Cardiovasc Drugs. 2016 Aug 19

Intracoronary Bivalirudin Bolus in ST-Elevation Myocardial Infarction Patients Treated with Primary Angioplasty: Theoretical Bases, Clinical Experience, and Future Applications.

Lupi A, Schaffer A, Rognoni A, Cavallino C, Bongo AS, Cortese B, Jaffe AS, Angiolillo DJ, Porto I.

– Catheter Cardiovasc Interv. 2016 Aug 12.

Intravascular imaging for spontaneous coronary artery dissection: A clinical-angiographic score may help the choice.

Buccheri D, Piraino D, Andolina G, Cortese B.

– Int J Cardiol. 2016 Jun 29;222:37-38.

Twenty-four months of follow-up of a “biodegradable” model for coronary artery bifurcation management. Insights from optical coherence tomography of a new interventional strategy.

Buccheri D, Cortese B.

– Int J Cardiol. 2016 Jun 28;220:589-594.

Treatment of bifurcation lesions with drug-coated balloons: A review of currently available scientific data.

Cortese B, Piraino D, Buccheri D, Alfonso F.

– J Am Coll Cardiol. 2016 Jun 21;67(24):2905-6.

The Contemporary Pulse of Bioresorbable-Scaffold Thrombosis Among Expert Operators.

Cortese B, Buccheri D, Stefanini GG, Mehran R.

– J Thorac Dis. 2016 Jun;8(6):E417-23.

Bioresorbable vascular scaffolds in patients with acute myocardial infarction: a new step forward to optimized reperfusion?

Alfonso F, Cuesta J, Bastante T, Rivero F, García-Guimaraes M, Alvarado T, Benedicto A, Cortese B, Byrne R, Kastrati A.

– Int J Cardiol. 2016 Jul 15;215:545.

Spontaneous coronary artery dissection: A hint into its diagnosis and therapy.

Buccheri D, Piraino D, Cortese B.

– Int J Cardiol. 2016 Jul 1;214:333-5.

Spontaneous coronary artery dissections: A call for action for an underestimated entity.

Buccheri D, Piraino D, Latini RA, Andolina G, Cortese B.

– Int J Cardiol. 2016 Jul 1;214:225-7.

Biovascular scaffolds and reversible coronary aneurysm.

Cortese B, Orrego PS, Yahagi K, Virmani R.

– Am J Cardiol. 2016 Jun 1;117(11):1859-61.

Drug-Coated Balloon for Instent Restenosis in Patients at High Risk: Another Brick in the Wall of the Challenging Settings for Interventionists.

Buccheri D, Piraino D, Andolina G, Cortese B, Seregni RG.

-Int J Cardiol. 2016 Jul 1;214:88-9.

Bioresorbable scaffolds for spontaneous coronary artery dissection: The ghost of thrombosis?

Buccheri D, Piraino D, Cortese B.

– Circ Cardiovasc Interv. 2016 Apr;9(4)

Long-Term Clinical Outcomes After Bioresorbable Vascular Scaffold Implantation for the Treatment of Coronary In-Stent Restenosis: A Multicenter Italian Experience.

Moscarella E, Ielasi A, Granata F, Coscarelli S, Stabile E, Latib A, Cortese B, Tespili M, Tanaka A, Capozzolo C, Caliendo L, Colombo A, Varricchio A.

– Int J Cardiol. 2016 Jul 1;214:43-5.

Intravascular imaging as a tool for definite diagnosis of acute coronary syndrome caused by spontaneous coronary artery dissection.

Buccheri D, Piraino D, Cortese B.

– Int J Cardiol. 2016 Jun 1;212:129-30.

A glimpse into first generation drug-eluting and bare metal stents ten years later with optical coherence tomography analysis.

Buccheri D, Cortese B.

– Catheter Cardiovasc Interv. 2016 Apr 1. doi: 10.1002/ccd.26516. [Epub ahead of print]

Bioresorbable vascular scaffolds for small vessels coronary disease: The BVS-save registry.

Latini RA, Granata F, Ielasi A, Varricchio A, Moscarella E, Tespili M, Cortese B.

– Int J Cardiol. 2016 Jun 1;212:44-6.

Sealing spontaneous coronary artery dissection with bioresorbable vascular scaffold implantation: Data from the prospective “Registro Absorb Italiano” (RAI Registry).

Ielasi A, Cortese B, Tarantini G, Loi B, Mazzarotto P, Gabrielli G, Tespili M, Rovera C, Corrado D, Steffenino G.

-JACC Cardiovasc Interv. 2016 Mar 14;9(5):506-7.

DCB and Dissections: In Search of a Good Balance Between Enthusiasm and Scientific Strictness.

Cortese B, Alfonso F.

– Int J Cardiol. 2016 Jan 11;207:37-38

Side branch occlusion after bioresorbable vascular scaffold implantation: Thickness of the scaffold or large plaque burden? Another building block in the comprehension of this complication.

Piraino D, Cortese B, Buccheri D, Andolina G.

– JACC Cardiovasc Interv. 2015 Dec 28;8(15):2003-9

Effect of Drug-Coated Balloons in Native Coronary Artery Disease Left With a Dissection.

Cortese B, Silva Orrego P, Agostoni P, Buccheri D, Piraino D, Andolina G, Seregni RG.

– Int J Cardiol. 2016 Jan 15;203:1125-6.

Is vasospasm overestimated in acute coronary syndromes presenting with non-obstructive coronary artery disease? The case for intravascular imaging.

Buccheri D, Piraino D, Orrego PS, Cortese B.

– Int J Cardiol. 2016 Jan 15;203:551-2

Paclitaxel-coated balloon exerts late vessel healing and enlargement: A documented phenomenon with optical coherence tomography analysis

Piraino D, Buccheri D, Cortese B.

– Int J Cardiol. 2016 Jan 15;203:298-300

Healing after coronary artery dissection: The effect of a drug coated balloon angioplasty in a bifurcation lesion. A lesson from intravascular ultrasound analysis

Piraino D, Cortese B, Buccheri D, Dendramis G, Andolina G.

– Minerva Cardioangiol. 2015 Oct 8

Performance of bioresorbable vascular scaffolds versus cobalt-chromium everolimus eluting stent in patients with ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention. A review of currently available clinical data

Buccheri D, Piraino D, Chirco PR, Cortese B.

– Int J Cardiol. 2016 Jan 1;202:77-9.

Immediate decision making in a case of iatrogenic dissection of left main coronary artery: A successful synergetic treatment.

La Franca E, Piraino D, Cortese B, Carella M, Buccheri D, Dendramis G, Andolina G, Assennato P, Argano V.

2015

– Catheter Cardiovasc Interv. 2015 Sep 14.

STEMI patients and nonculprit lesions: To treat or not to treat? and when? A review of most recent literature

Ruggieri A, Piraino D, Dendramis G, Cortese B, Carella M, Buccheri D, Andolina G, Assennato P.

– N Engl J Med. 2015 Sep 10;373(11):997-1009.

Bivalirudin or Unfractionated Heparin in Acute Coronary Syndromes

Valgimigli M, Frigoli E, Leonardi S, Rothenbühler M, Gagnor A, Calabrò P, Garducci S, Rubartelli P, Briguori C, Andò G, Repetto A, Limbruno U, Garbo R, Sganzerla P, Russo F, Lupi A, Cortese B, Ausiello A, Ierna S, Esposito G, Presbitero P, Santarelli A, Sardella G, Varbella F, Tresoldi S, de Cesare N, Rigattieri S, Zingarelli A, Tosi P, van ‘t Hof A, Boccuzzi G, Omerovic E, Sabaté M, Heg D, Jüni P, Vranckx P; MATRIX Investigators.

– JACC Cardiovasc Interv. 2015 Aug 24;8(10):e171-2.

Late Structural Discontinuity as a Possible Cause of Very Late Everolimus-Eluting Bioresorbable Scaffold Thrombosis.

Ielasi A, Cortese B, Steffenino G.

– J Cardiovasc Med (Hagerstown). 2015 Aug 7. [Epub ahead of print]

Effects of drug-eluting stents after rotational atherectomy: evidence from a multicenter experience

Cortese B, Piraino D, Godino C, Aranzulla T, Chizzola G, Ettori F, De Benedictis M, Colombo A.

– Int J Cardiol. 2015 Nov 15;199:119-20.

Drug-eluting stent treatment of left main coronary artery disease: the case for a sirolimus-eluting, autoexpandable alternative. An optical coherence tomography analysis

Buccheri D, Orrego PS, Cortese B.

– Eur Heart J Acute Cardiovasc Care. 2015 Jul 10.

Intracoronary vs intravenous bivalirudin bolus in ST-elevation myocardial infarction patients treated with primary angioplasty

Lupi A, Rognoni A, Cavallino C, Secco GG, Reale D, Cossa G, Rosso R, Bongo AS, Cortese B, Angiolillo DJ, Jaffe AS, Porto I.

– Catheter Cardiovasc Interv. 2015 Nov 1;86(5):950-7

Acute kidney injury after percutaneous coronary intervention: Rationale of the AKI-MATRIX (acute kidney injury-minimizing adverse hemorrhagic events by TRansradial access site and systemic implementation of angioX) sub-study

Andò G, Cortese B, Frigoli E, Gagnor A, Garducci S, Briguori C, Rubartelli P, Calabrò P, Valgimigli M; MATRIX investigators.

-Eur Heart J. 2015 May 24

Drug-coated balloon treatment for lower extremity vascular disease intervention: an international positioning document

Cortese B, Granada JF, Scheller B, Schneider PA, Tepe G, Scheinert D, Garcia L, Stabile E, Alfonso F, Ansel G, Zeller T.

-Cardiovasc Revasc Med. 2015 Jun 3.

Registro Absorb Italiano (BVS-RAI): an investigators-owned and -directed, open, prospective registry of consecutive patients treated with the Absorb™ BVS: study design.

Cortese B, Ielasi A, Varricchio A, Tarantini G, LaVecchia L, Pisano F, Facchin M, Gistri R, D’Urbano M, Lucci V, Loi B, Tumminello G, Colombo A, Limbruno U, Nicolino A, Calzolari D, Tognoni G, Defilippi G, Buccheri D, Tespili M, Corrado D, Steffenino G; BVS-RAI investigators.

-Am J Cardiol. 2015 2015 Sep 1;116(5):705-10.

Clinical Comparison With Short-Term Follow-Up of Bioresorbable Vascular Scaffold Versus Everolimus-Eluting Stent in Primary Percutaneous Coronary Interventions.

Cortese B, Ielasi A, Romagnoli E, Varricchio A, Cuculo A, Loi B, Pisano F, Corrado D, Sesana M, La Vecchia L, Summaria F, Tespili M, Silva Orrego P, Tognoni G, Steffenino G.

-Heart Lung Circ. 2015 Aug;24(8):e130-2.

Effective Treatment of Intermediate-Risk Pulmonary Embolism by Manual Thrombus Aspiration. A Report of Two Cases.

Sebik R, Cortese B, Buccheri D, Silva-Orrego P, Rubboli A.

-Int J Cardiol. 2015 Jul 15;191:75-6.

Drug-coated balloon without stent implantation for chronic total occlusion of coronary arteries: Description of a new strategy with an optical coherence tomography assistance.

Cortese B, Buccheri D, Piraino D, Silva-Orrego P.

-Int J Cardiol. 2015 Jun 15;189:132-3.

Very late bioresorbable vascular scaffold thrombosis due to late device recoil.

Cortese B, Piraino D, Ielasi A, Steffenino G, Orrego PS.

-Int J Cardiol 2015;189:257-8.

Drug-coated balloon angioplasty: An intriguing alternative for the treatment of coronary chronic total occlusions.

Cortese B, Buccheri D, Piraino D, Silva-Orrego P, Seregni R.

-The Lancet, 2015, Jun 20;385(9986):2465-76.

Radial versus femoral access in patients with acute coronary syndromes undergoing invasive management: a randomised multicentre trial.

Valgimigli M, Gagnor A, Calabró P, Frigoli E, Leonardi S, Zaro T, Rubartelli P, Briguori C, Andò G, Repetto A, Limbruno U, Cortese B, Sganzerla P, Lupi A, Galli M, Colangelo S, Ierna S, Ausiello A, Presbitero P, Sardella G, Varbella F, Esposito G, Santarelli A, Tresoldi S, Nazzaro M, Zingarelli A, de Cesare N, Rigattieri S, Tosi P, Palmieri C, Brugaletta S, Rao SV, Heg D, Rothenbühler M, Vranckx P, Jüni P; MATRIX Investigators.

Int J Cardiol. 2015 Apr 1;184:499-501.

Left main coronary artery and ostial left anterior descending coronary artery stenting in a single coronary artery during NSTEMI. The OCT response.

Buccheri D, Cortese B, Piraino D, Orrego PS, Seregni R.

-JACC Cardiovasc Interv. 2015 Mar;8(3):424-33

Outcomes With Cangrelor Versus Clopidogrel on a Background of Bivalirudin: Insights From the CHAMPION PHOENIX (A Clinical Trial Comparing Cangrelor to Clopidogrel Standard Therapy in Subjects Who Require Percutaneous Coronary Intervention [PCI]).

White HD, Bhatt DL, Gibson CM, Hamm CW, Mahaffey KW, Price MJ, Steg PG, Stone GW, Cortese B, Wilensky M, Deliargyris EN, Liu T, Prats J, Harrington RA.

-Eurointervention, 2015 Mar 22;10(11):1311-7

Optical coherence tomography appraisal of residual thrombus burden in patients with ST-segment elevation myocardial infarction undergoing intraprocedural versus post-stenting prolonged bivalirudin infusion. Rationale and design of the MATRIX (Minimizing Adverse Haemorrhagic Events by TRansradial Access Site and angioX) OCT substudy.

Picchi A, Limbruno U, Andò G, Brugaletta S, Cortese B, De Carlo M, Garcia-Garcia HM, Palmieri C, Regar E, Rigattieri S, Sardella G, Zimarino M, Valgimigli M.

-Journal of invasive cardiology, 2015 Aug;27(8):E171-2.

Late malapposition after bare metal stent, but not bioresorbable scaffold: insights on intra-individual heterogeneity in plaque and device response.

Cortese B, Dario Buccheri, Pedro Silva Orrego,Giuseppe Biondi-Zoccai

– J Cardiovasc Med (Hagerstown). 2016 Sep;17(9):665-72

Drug-eluting stent use after coronary atherectomy: results from a multicentre experience – The ROTALINK I study.

Cortese B, Aranzulla TC, Godino C, Chizzola G, Zavalloni D, Tavasci E, De Benedictis M, Ettori F, Presbitero P, Colombo A.

-Am J Cardiol. 2015 Feb 15;115(4):555-6

A new, intriguing hypothesis: does bivalirudin reduce the risk of acute kidney disease?

Cortese B, Sciahbasi A, Rigattieri S, Ricci R.

-Catheter Cardiovasc Interv. 2014 Dec 13. doi: 10.1002/ccd.25766. [Epub ahead of print]

Late coronary BVS malapposition and aneurysm: A time for appraisal.

Cortese B, Silva Orrego P, Virmani R.

-Int J Cardiol. 2015 Feb 1;180:203-5. doi: 10.1016/j.ijcard.2014.11.168. Epub 2014 Nov

Current know how on the Absorb BVS technology: An experts’ survey.

Cortese B, Valgimigli M.

2014

-Am Heart J. 2014 Dec;168(6):838-45

Design and rationale for the Minimizing Adverse haemorrhagic events by TRansradial access site and systemic Implementation of angioX program.

Valgimigli M; MATRIX investigators.

-EuroIntervention. 2014 Oct 30. [Epub ahead of print]

Immediate and midterm outcomes following primary PCI with bioresorbable vascular scaffold implantation in patients with ST-segment myocardial infarction: insights from the multicentre “Registro ABSORB Italiano” (RAI registry).

Ielasi A, Cortese B, Varricchio A, Tespili M, Sesana M, Pisano F, Loi B, Granata F, Moscarella E, Silva Orrego P, La Vecchia L, Steffenino G.

-EuroIntervention. 2014 Aug;10 Suppl T:T64-73.

The conundrum of antithrombotic drugs before, during and after primary PCI.

Cortese B, Sebik R, Valgimigli M.

-Int J Cardiol. 2014 Dec 15;177(2):497-9.

Biovascular scaffolding of distal left main trunk: experience and follow up from the multicenter prospective RAI registry (Registro Italiano Absorb)

Cortese B, Orrego PS, Sebik R, Sesana M, Pisano F, Zavalloni D, Steffenino G, Seregni R; RAI registry investigators.

-Am J Cardiol. 2014 Sep 15;114(6):820-5.

Comparison of risk of  after primary percutaneous coronary interventions with the transradial approach versus the transfemoral approach (from the PRIPITENA urban registry).

Cortese B, Sciahbasi A, Sebik R, Rigattieri S, Alonzo A, Silva-Orrego P, Belloni F, Seregni RG, Giovannelli F, Tespili M, Ricci R, Berni A.

-G Ital Cardiol (Rome). 2014 Apr;15(4):205-8.

The TASTE study.

Sardella G, Pennacchi M, Cortese B, Silva Orrego P.

-Int J Cardiol. 2014 Aug 1;175(2):280-4.

Safety and feasibility of iliac endovascular interventions with a radial approach. Results from a multicenter study coordinated by the Italian Radial Force.

Cortese B, Trani C, Lorenzoni R, Sbarzaglia P, Latib A, Tommasino A, Bovenzi F, Cremonesi A, Burzotta F, Pitì A, Tarantino F, Colombo A.

-Catheter Cardiovasc Interv. 2015 Feb 1;85(2):218-24.

One-year follow-up of patients treated with new-generation polymer-based 38 mm everolimus-eluting stent: The P38 study.

Sgueglia GA, Belloni F, Summaria F, Conte M, Cortese B, Silva PL, Ricci R, Lioy E, Pucci E, Gaspardone A.

-Int J Cardiol. 2014 Jul 1;174(3):e90-2.

Coronary dissection at site of recent BRS deployment: a case for the comeback kid?

Cortese B, Sebik R, Silva PL, Seregni R.

– Cardiovasc Revasc Med. 2014 Mar 26

Randomized comparison of operator radiation exposure comparing transradial and transfemoral approach for percutaneous coronary procedures: rationale and design of the minimizing adverse haemorrhagic events by TRansradial access site and systemic implementation of angioX – RAdiation Dose study (RAD-MATRIX).

Sciahbasi A, Calabrò P, Sarandrea A, Rigattieri S, Tomassini F, Sardella G, Zavalloni D, Cortese B, Limbruno U, Tebaldi M, Gagnor A, Rubartelli P, Zingarelli A, Valgimigli M.

– Int J Cardiol. 2014 May 15;173(3):513-4.

Early results following everolimus-eluting bioresorbable vascular scaffold implantation for the treatment of in-stent restenosis.

Ielasi A, Latib A, Naganuma T, Cortese B, Sato K, Miyazaki T, Panoulas VF, Tespili M, Colombo A.

– Int J Cardiol. 2014 May 15;173(3):e67-9

Bioresorbable scaffolding after drug-coated balloons: A new chapter of the “leave nothing behind” saga.

Cortese B, Sebik R, Seregni R, Silva PL.

– Atherosclerosis. 2014 Mar;233(1):224-231.

Short and long-term safety and efficacy of polymer-free vs. durable polymer drug-eluting stents. A comprehensive meta-analysis of randomized trials including 6178 patients.

Navarese EP, Kowalewski M, Cortese B, Kandzari D, Dias S, Wojakowski W, Buffon A, Lansky A, Angelini P, Torguson R, Kubica J, Kelm M, de Boer MJ, Waksman R, Suryapranata H.

– Eur Heart J Acute Cardiovasc Care. 2014 Jan 15

Bivalirudin or heparin in primary angioplasty performed through the transradial approach: results from a multicentre registry.

Sciahbasi A, Rigattieri S, Cortese B, Belloni F, Russo C, Ferraironi A, Tespili M, Angeletti C, Ricci R, Bondanini F, Pugliese FR.

– J Cardiovasc Transl Res. 2014 Feb;7(1):101-11.

Scientific Foundation and Possible Implications for Practice of the Minimizing Adverse Haemorrhagic Events by Transradial Access Site and Systemic Implementation of AngioX (MATRIX) Trial.

Valgimigli M, Calabrò P, Cortese B, Frigoli E, Garducci S, Rubartelli P, Andò G, Santarelli A, Galli M, Garbo R, Repetto A, Ierna S, Briguori C, Limbruno U, Violini R, Gagnor A; MATRIX investigators.

2013

-Am Heart J. 2013 Dec;166(6):1019-26

Radial versus femoral approach comparison in percutaneous coronary intervention with intraaortic balloon pump support: The RADIAL PUMP UP Registry.

Romagnoli E, De Vita M, Burzotta F, Cortese B, Biondi-Zoccai G, Summaria F, Patrizi R, Lanzillo C, Lucci V, Cavazza C, Tarantino F, Sangiorgi GM, Lioy E, Crea F, Rao SV, Trani C.

– G Ital Cardiol (Rome). 2013 Oct;14(10):681-9. doi: 10.1714/1335.14836. Italian.

SICI-GISE position paper on drug-coated balloon use in the coronary district

Cortese B, Sgueglia GA, Berti S, Biondi-Zoccai G, Colombo A, Limbruno U, Bedogni F, Cremonesi A.

– Catheter Cardiovasc Interv. 2013 Aug 9. doi: 10.1002/ccd.25149.

Drug-coated balloon treatment of coronary artery disease: A position paper of the Italian Society of Interventional Cardiology.

Cortese B, Berti S, Biondi-Zoccai G, Colombo A, Limbruno U, Bedogni F, Cremonesi A, Silva PL, Sgueglia GA.

– J Cardiovasc Med (Hagerstown). 2013. [Epub ahead of print]

Design of the ROSuvastatin Pretreatment to Reduce Embolization during Carotid Artery Stenting (ROSPREC) trial

Marco De Carlo, Bernardo Cortese, Matteo Pennesi, Leonardo Misuraca, Lorenzo Conte, Antonino Pitì, A. Sonia Petronio, Alberto Balbarini

– Eurointervention. 2014 Aug;10:513-7

Distal embolization during carotid stenting is predicted by circulating levels of LDL cholesterol and C-reactive protein

Bernardo Cortese, Marco De Carlo, Sara De Matteis, Antonio Rizza, Danilo Giannini, Cataldo Palmieri, Anna Sonia Petronio, Sergio Berti, Alberto Balbarini, Steve Ramee

– Eurointervention. 2013 (in press)

How should I treat a BVS restenosis?

Bernardo Cortese, Franco Fabbiocchi, Romano Seregni, Pedro Leon Silva Orrego

^– Eurointervention. 2013 (in press)

How did I treat the BVS restenosis?

Bernardo Cortese, Franco Fabbiocchi, Romano Seregni, Pedro Leon Silva Orrego,

– J Cardiovasc Med (Hagerstown). 2013 Jun 27. [Epub ahead of print]

Refining the assessment of contrast-induced acute kidney injury: the load-to-damage relationship.

Limbruno U, Picchi A, Micheli A, Calabria P, Cortese B, Brizi G, Severi S, De Caterina R.

– Int J Cardiol. 2013 Sep 30;168(2):638-9.

 Late catch-up phenomenon after drug-eluting balloon angioplasty.

Sgueglia GA, Cortese B, Gaspardone A.

2012

-Int J Cardiovasc Research, 2012,1:4

Modified Chimney Technique for the Emergent Treatment
of Abdominal Aortic Graft Rupture: A Cardiologist’s Point of View

Bernardo Cortese, et al.

Interventional Cardiology, A.O. Fatebenefratelli, Milano, Italy

-Circulation, 2012, Nov 20;126(21):e333

Percutaneous coronary interventions in patients on dialysis, the son of a forgotten child?

Bernardo Cortese, and Marco Valgimigli

Interventional Cardiology, A.O. Fatebenefratelli, Milano, Italy

-JACC Cardiovascular Interventions, 2012, Oct;5(10):1093

The future is now- comment on a recent editorial suggesting the need for a new technology in the treatment of DES restenosis

Bernardo Cortese, Gregory A. Sgueglia

–Cardiovascular Revascularization Medicine, 2012, Nov;13(6):331-4

Transradial percutaneous iliac intervention, a feasible alternative to the transfemoral route

Bernardo Cortese, Elisa Peretti, Nicola Troisi, Emanuele Siquilberti, Marco Setti, Antonino Pitì

-Scientific basis of healthcare: Angina Pectoris (book Chapter), Science Publisher, 2011

Current clinical application of direct thrombin inhibitors in angina pectoris

Bernardo Cortese, and Marco Centola,

-Int J Cardiol. 2012 May 31.

Paclitaxel coated balloons, the time for awareness has come.

Cortese B, Sgueglia GA, Granada JF.

-Int J Cardiol. 2012 Feb 20.

Bivalirudin has its own shelf in the cath lab, eventually.

Cortese B, Pitì A.

-Curr Vasc Pharmacol. 2012 Jul;10(4):476-8.

In the bivalirudin era, are we still looking for a potent antiplatelet agent?

Cortese B, Piti A, Kastrati A, Sibbing D.

-Curr Vasc Pharmacol. 2012 Jul;10(4):442.

Current antithrombotic management of ST elevation acute coronary syndromes in the cath lab–a paradigm shift.

Cortese B.

2011

-Int J Cardiol, 2011 Sept 26

Paclitaxel coated balloons for coronary artery interventions: A comprehensive review of preclinical and clinical data

Cortese B, Bertoletti A

-J Interv Cardiol, 2011 Oct 24

The original Sin committed in years 2000

Cortese B

-Am J Cardiol, 2011 Nov 1

Effect of Prolonged Bivalirudin Infusion on ST-Segment Resolution Following Primary Percutaneous Coronary Intervention (from the PROBI VIRI 2 Study).

Cortese B, Limbruno U, Severi S, De Matteis S, Diehl L, Pitì A.

-Am J Phisiol Heart Physiol, 2011 Oct 7

Increased coronary blood flow as a cause of reduced flow reserve in diabetic patients

Picchi A, Limbruno U, Focardi M, Cortese B et al

-Journal of Interventional Cardiology, vol 24, n° 5, 2011

Transradial Percutaneous Coronary Interventions Using Sheathless Guiding Catheters: A Multicenter Registry

Sciahbasi A, Mancone M, Cortese B, et al.

-Heart, 2011 Nov 97

Transradial primary PCI: this is the time for awareness

Cortese B

-Eurointervention, May 2011;7

The PICCOLETO study and beyond

Cortese B

-Treatment Strategies in Interventional Cardiology, Vol I, Issue 1 Apr 2011

Paclitaxel-coated Balloons in Native Coronary Arteries: A Step Back?

Cortese B

-Int. J Cardiol. 2011 May 12.

Drug-eluting stents perform better than bare metal stents in small coronary vessels: A meta-analysis of randomised and observational clinical studies with mid-term follow up

Cortese B, Bertoletti A, De Matteis S, Danzi GB, Kastrati A

– Lancet. 2011 Apr 23;377(9775):1409-20.

Radial versus femoral access for coronary angiography and intervention in patients with acute coronary syndromes (RIVAL): a randomised, parallel group, multicentre trial.

Jolly SS, Yusuf S, Cairns J, et Al.

– Catheter Cardiovasc Interv. 2011 Mar 16

Rationale and design of the randomized, multicenter EREMUS trial, a study that investigates how to achieve low restenosis and early reendothelialization after percutaneous coronary interventions.

Cortese B, Danzi GB, Pitì A, Severi S, Limbruno U.

2010

-J Cardiovasc Med (Hagerstown). 2010 Aug 20

Intracoronary drugs during percutaneous interventions: the highway has different lanes!

B Cortese, G Biondi-Zoccai

– Am J Cardiol. 2010 Sep 15;106(6):770-3. Epub 2010 Aug 2

Usefulness of primary angioplasty in nonagenarians with acute myocardial infarction.

Danzi GB, Centola M, Pomidossi GA, Consonni D, De Matteis S, Stabile A, Sesana M, Anzuini A, Sganzerla P, Cortese B, Migliorini A, Antoniucci D

-Heart, 2010 Aug;96(16):1291-6

Paclitaxel-coated balloon versus drug-eluting stent during PCI of small coronary vessels, a prospective randomized trial. The PICCOLETO study

B Cortese, A Micheli, A Picchi, A. Coppolaro, L. Bandinelli, S. Severi, U. Limbruno

American Journal of Hematology, 2010 Jul;85(7):546.

A comment on ‘Laboratory monitoring of new anticoagulants

B Cortese

Fondazione IRCCS Ospedale Maggiore Policlinico Milano, Italy

–International Journal of Cardiology, 2010, Mar 4

Transradial access compared with femoral puncture closure devices in percutaneous coronary procedures”: an underestimated revolution

B Cortese

–American Journal of Cardiology, 2010, 2010 Apr 1;105(7):1044-5

Optimal Dual Antiplatelet Treatment after Drug-Eluting Stent Implantation: it’s Not the Time for Weaning

B Cortese, G.B. Danzi

–Future Cardiology, 2010 Mar;6(2):221-30

Coronary bifurcation lesions: innovative approaches and the future of bifurcation devices

B Cortese, U. Limbruno

–Heart, 2010 Jul;96(14):1167

Radial Force

B Cortese

-N Eng J Med, 2009 Dec 10;361(24):2330-41

Intravenous platelet blockade with cangrelor during PCI

Bhatt DL, Lincoff AM, Gibson CM et al.

– J Clin Ultrasound, 2009 Dec 10;38(3):156-160

Contrast-enhanced sonography in the diagnosis of acute mesenteric ischemia: Case report

Giannetti A, Biscontri M, Randisi P, Cortese B, Minacci C, Stumpo M.

–Catheterization and Cardiovascular Interventions, 2010, Feb 1;75:283-5

Acute Mesenteric Ischemia: Primary Percutaneous Therapy

B. Cortese and U. Limbruno

2009

–American Heart Journal, 2009, Oct;158(4):e59

Are we sure we have taken the best from clopidogrel?

B. Cortese, A. Picchi, A. Micheli, and U. Limbruno.

–American Journal of Cardiology, October 2009, 15;104(8):1063-8

Comparison of Prolonged Bivalirudin Infusion Versus Intraprocedural in Preventing Myocardial Damage After Percutaneous Coronary Intervention in Patients with Angina Pectoris. The PROBI VIRI Study

B. Cortese, A. Picchi, A. Micheli, Alberto Genovesi Ebert, Francesca Parri,  Silva Severi and Ugo Limbruno.

–Coronary Artery Disease, 2009, Jun 18.

“Safety and efficacy of a prolonged bivalirudin infusion after urgent and complex PCI. A descriptive study.”

B. Cortese, A. Micheli, A. Picchi, L. Bandinelli, M.G. Brizi, S. Severi, U. Limbruno

-Indian Heart Journal, 2008; 60:605-607

A New Technique for the Treatment of Bifurcation Lesions: Modified Reverse Crushing

B. Cortese, U. Limbruno

-Journal of Invasive Cardiology, 2009 Apr;21(4):168-71

Combined, superselective pharmacological management of large coronary thrombus burden

B. Cortese, A. Micheli, A. Picchi, U. Limbruno

2008

–Minerva Medica, 2008 October, vol 99, suppl I, n° 5

Safety and efficacy of a prolonged bivalirudin infusion after urgent PCI

B. Cortese, A. Micheli, A. Pichi, S. Severi, U. Limbruno

-J Thromb Thrombolysis, 2008, Jul 3

Intracoronary bivalirudin for no reflow reversal: a second chance to treat this disorder?

–Thrombosis and Haemostasis, 2008 Jun;99(6):1116-8

Acute ST-elevation Myocardial Infarction in a 15-year-old boy with celiac disease and multifactorial thrombotic risk: a case report

Picchi, P. Pasqualini, N. D’Aiello, B. Cortese, A. Micheli, U. Limbruno

–Catheterization and Cardiovascular Interventions, 2008, Aug 1;72(2):196-203

Adjunctive Use of the Rinspiration System for Fluidic Thrombectomy During Primary    Angioplasty: the Rinspiration International Registry

M. De Carlo, D. Wood, J. Webb, U. Gerckens, B. Cortese, E. Grube, G.B. John Mancini, M.W. Krucoff, C. McQueen, T. Goff, A.S. Petronio, J.N. Hamburger

–Journal of Cardiovascular Medicine, 2008 Apr;9(4):408-9

“Thrombectomy for thrombus removal, filter for whatever else”

U. Limbruno, B. Cortese, S. Severi

2007

-J Cardiovasc Med (Hagerstown). 2007 Nov;8(11):934-6

“Transient left ventricular apical ballooning syndrome: all that glitters is not apical”

Bernardo Cortese, Stefano Robotti, Enrico Puggioni, Federico Bianchi, Gabriele Lupi, Michelino Brignole

–Journal Of The American College Of Cardiology, 2007 Feb 6; 49:539-546

Randomized Comparison of Sirolimus and Paclitaxel Drug-Eluting Stents for Long Lesions in the Left Anterior Descending Artery,An Intravascular Ultrasound Study

Anna Sonia Petronio, Marco De Carlo, Giulia Branchitta, Barbara Papini, Nicola Ciabatti, Roberto Gistri, Bernardo Cortese, Gherardo Gherarducci, and Antonio Barsotti.

–International Journal of Cardiology, 2007, Apr 10

Emergency coronary artery bypass grafting in patients with acute myocardial infarction treated with glycoprotein IIb/IIIa receptor inhibitors

De Carlo M, Maselli D, Cortese B, Ciabatti N, Gistri R, Levantino M, Balbarini A, De Caterina R, Petronio AS.

–International Journal of Cardiology, 2007, Feb 12

Coronary embolization of a proximal vessel due to retrieval of a balloon catheter with an organized thrombus during primary PCI

B Cortese, Enrico Puggioni, Stefano Robotti, Federico Bianchi, Michelino Brignole

-International Journal of Cardiology, Jan 31, 2007;115(1):95-6

“Successful treatment of acute myocardial infarction due to subocclusive thrombosis over a small atheroscerotic plaque with the “Rinspiration” device, a novel thrombectomy catheter”

M De Carlo, B Cortese, et Al.

2006

–Final Rinspirate IT report, March 12, 2006

“Rinspirate IT clinical registry

B Cortese

-Cardiology Science, vol 4, maggio-giugno 2006

Markers precoci di ischemia miocardica

M De Carlo, B Cortese

-Primula Edizioni (book chapter)

La gestione del paziente scompensato: il ruolo del medico di medicina generale in accordo con il cardiologo

Rita Mariotti e coll.

2005

-Bradipolibri (book chapter)

Gente di palestra. Capitolo “intervista sul Doping in Italia”

T. Vezzosi, B. Cortese, 2005

2004

-European Heart Journal Supplements (volume 6, Issue 1006, November 2004). New Perspectives in Heart Failure

Obesity, weight loss and heart failure (pages F87-F90 )

Rita Mariotti, Francesca Castrogiovanni, Francesco Becherini, Bernardo Cortese, Lorenzo Rondinini and Mario Mariani

-Transplant. Proc. 2004 Apr;36(3):457-9.

Echocardiographic evaluation in type 1 diabetic patients on waiting list for isolated pancreas or kidney-pancreas transplantation

Rondinini L, Mariotti R, Cortese B, Rizzo G, Marchetti P, Giannarelli R, Coppelli A, Fossati N, Boggi U, Mariani M.

–European Journal of Heart Failure Suppl, vol 3, Iss 1, pag 132 (European Society of Cardiology congress, 2004):

Influence of right ventricular function on clinical conditions in Heart Failure

Rita Mariotti, Lorenzo Rondinini, Bernardo Cortese, Mario Mariani.